# background genes,# genes,category,chart color,description,FDR value,genes,network.SUID,nodes.SUID,p-value,PMID,term name,transferred FDR value,year
71,6,WikiPathways,,miRNA regulation of DNA damage response,1.75E-09,CDK2|TP53|CASP3|E2F1|CDK1|CREB1,35655,35750|35771|35777|35768|35765|35759,2.64E-12,,WP1530,1,0
69,6,WikiPathways,,DNA damage response,1.75E-09,CDK2|TP53|CASP3|E2F1|CDK1|CREB1,35655,35750|35771|35777|35768|35765|35759,2.25E-12,,WP707,1,0
67,6,STRING Clusters,,"Mixed, incl. G1 Phase, and G0 and Early G1",8.69E-09,CDK2|TP53|E2F1|TP73|CDK1|HIPK2,35655,35750|35771|35768|35774|35765|35747,1.90E-12,,CL:6897,0.920522468,0
175,7,Reactome Pathways,,Apoptosis,8.86E-09,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|CTNNB1,35655,35762|35771|35777|35744|35768|35774|35753,3.88E-12,,HSA-109581,0.919561638,0
40,5,WikiPathways,,ATM signaling pathway,1.00E-08,CDK2|TP53|TP73|CDK1|CREB1,35655,35750|35771|35774|35765|35759,3.86E-11,,WP2516,0.91355884,0
44,5,WikiPathways,,Integrated cancer pathway,1.17E-08,CDK2|TP53|CASP3|E2F1|CDK1,35655,35750|35771|35777|35768|35765,6.02E-11,,WP1971,0.905772365,0
1215,10,Reactome Pathways,,Generic Transcription Pathway,3.72E-08,SKP1|CASP6|CDK2|TP53|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35768|35774|35765|35747|35759|35753,4.88E-11,,HSA-212436,0.848405771,0
1518,11,GO Biological Process,,Intracellular signal transduction,3.77E-08,CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,6.60E-12,,GO:0035556,0.847743623,0
318,8,GO Biological Process,,Apoptotic signaling pathway,3.77E-08,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|HIPK2|CTNNB1,35655,35762|35771|35777|35744|35768|35774|35747|35753,2.40E-12,,GO:0097190,0.847743623,0
166,7,GO Biological Process,,Intrinsic apoptotic signaling pathway,3.77E-08,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|HIPK2,35655,35762|35771|35777|35744|35768|35774|35747,2.71E-12,,GO:0097193,0.847743623,0
64,5,WikiPathways,,Oncostatin M signaling pathway,5.50E-08,CDK2|TP53|CASP3|PRKCD|CREB1,35655,35750|35771|35777|35744|35759,3.52E-10,,WP2374,0.82901323,0
64,5,WikiPathways,,G1 to S cell cycle control,5.50E-08,CDK2|TP53|E2F1|CDK1|CREB1,35655,35750|35771|35768|35765|35759,3.52E-10,,WP45,0.82901323,0
534,8,UniProt Keywords,,Apoptosis,9.38E-08,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2,35655,35762|35771|35777|35744|35768|35774|35765|35747,1.40E-10,,KW-0053,0.802538278,0
72,5,KEGG Pathways,,p53 signaling pathway,2.08E-07,CDK2|TP53|CASP3|TP73|CDK1,35655,35750|35771|35777|35774|35765,6.18E-10,,hsa04115,0.763042788,0
361,7,Reactome Pathways,,Transcriptional Regulation by TP53,2.08E-07,CASP6|CDK2|TP53|E2F1|TP73|CDK1|HIPK2,35655,35762|35750|35771|35768|35774|35765|35747,5.46E-10,,HSA-3700989,0.763042788,0
95,5,WikiPathways,,Small cell lung cancer,2.61E-07,SKP1|CDK2|TP53|CASP3|E2F1,35655,35756|35750|35771|35777|35768,2.34E-09,,WP4658,0.751785782,0
97,5,KEGG Pathways,,Prostate cancer,4.35E-07,CDK2|TP53|E2F1|CREB1|CTNNB1,35655,35750|35771|35768|35759|35753,2.59E-09,,hsa05215,0.726451797,0
109,5,WikiPathways,,Androgen receptor network in prostate cancer,4.43E-07,CDK2|TP53|CASP3|E2F1|CDK1,35655,35750|35771|35777|35768|35765,4.54E-09,,WP2263,0.725548005,0
115,5,WikiPathways,,Spinal cord injury,4.90E-07,CDK2|TP53|CASP3|E2F1|CDK1,35655,35750|35771|35777|35768|35765,5.89E-09,,WP2431,0.720547144,0
114,5,WikiPathways,,CKAP4 signaling pathway map,4.90E-07,TP53|CASP3|E2F1|CDK1|CTNNB1,35655,35771|35777|35768|35765|35753,5.64E-09,,WP5322,0.720547144,0
120,5,WikiPathways,,Cell cycle,5.14E-07,SKP1|CDK2|TP53|E2F1|CDK1,35655,35756|35750|35771|35768|35765,7.23E-09,,WP179,0.718175655,0
56,5,GO Biological Process,,Intrinsic apoptotic signaling pathway by p53 class mediator,7.33E-07,CASP6|TP53|E2F1|TP73|HIPK2,35655,35762|35771|35768|35774|35747,1.87E-10,,GO:0072332,0.700573562,0
120,5,KEGG Pathways,,Cell cycle,8.10E-07,SKP1|CDK2|TP53|E2F1|CDK1,35655,35756|35750|35771|35768|35765,7.23E-09,,hsa04110,0.69561967,0
3166,12,GO Biological Process,,Positive regulation of nitrogen compound metabolic process,9.51E-07,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,3.03E-10,,GO:0051173,0.687660803,0
150,5,KEGG Pathways,,Cellular senescence,1.50E-06,CDK2|TP53|E2F1|CDK1|HIPK2,35655,35750|35771|35768|35765|35747,2.14E-08,,hsa04218,0.665060414,0
157,5,KEGG Pathways,,Hepatitis C,1.50E-06,CDK2|TP53|CASP3|E2F1|CTNNB1,35655,35750|35771|35777|35768|35753,2.66E-08,,hsa05160,0.665060414,0
158,5,KEGG Pathways,,Hepatitis B,1.50E-06,CDK2|TP53|CASP3|E2F1|CREB1,35655,35750|35771|35777|35768|35759,2.75E-08,,hsa05161,0.665060414,0
324,6,KEGG Pathways,,Human papillomavirus infection,1.50E-06,CDK2|TP53|CASP3|E2F1|CREB1|CTNNB1,35655,35750|35771|35777|35768|35759|35753,1.79E-08,,hsa05165,0.665060414,0
1041,9,GO Biological Process,,Apoptotic process,1.66E-06,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CTNNB1,35655,35762|35771|35777|35744|35768|35774|35765|35747|35753,6.36E-10,,GO:0006915,0.660033919,0
1058,9,GO Biological Process,,Response to nitrogen compound,1.66E-06,CASP6|CDK2|TP53|CASP3|PRKCD|TP73|CDK1|CREB1|CTNNB1,35655,35762|35750|35771|35777|35744|35774|35765|35759|35753,7.33E-10,,GO:1901698,0.660033919,0
3533,12,GO Biological Process,,Positive regulation of macromolecule metabolic process,1.97E-06,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,1.13E-09,,GO:0010604,0.651542602,0
422,7,GO Biological Process,,Response to xenobiotic stimulus,2.26E-06,TP53|CASP3|E2F1|TP73|CDK1|CREB1|CTNNB1,35655,35771|35777|35768|35774|35765|35759|35753,1.59E-09,,GO:0009410,0.644731768,0
55,4,WikiPathways,,DNA IR-double strand breaks and cellular response via ATM,2.29E-06,TP53|CASP3|E2F1|TP73,35655,35771|35777|35768|35774,3.52E-08,,WP3959,0.644077769,0
187,5,KEGG Pathways,,Kaposi sarcoma-associated herpesvirus infection,2.36E-06,TP53|CASP3|E2F1|CREB1|CTNNB1,35655,35771|35777|35768|35759|35753,6.24E-08,,hsa05167,0.642584498,0
183,5,KEGG Pathways,,Viral carcinogenesis,2.36E-06,CDK2|TP53|CASP3|CDK1|CREB1,35655,35750|35771|35777|35765|35759,5.61E-08,,hsa05203,0.642584498,0
38,4,Reactome Pathways,,Apoptotic cleavage of cellular proteins,2.84E-06,CASP6|CASP3|PRKCD|CTNNB1,35655,35762|35777|35744|35753,8.70E-09,,HSA-111465,0.633402508,0
540,7,UniProt Keywords,,Host-virus interaction,2.88E-06,SKP1|TP53|E2F1|TP73|CDK1|CREB1|CTNNB1,35655,35756|35771|35768|35774|35765|35759|35753,8.57E-09,,KW-0945,0.632708871,0
1146,9,COMPARTMENTS,,Nucleoplasm,3.41E-06,SKP1|CDK2|TP53|CASP3|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35750|35771|35777|35768|35765|35747|35759|35753,1.48E-09,,GOCC:0005654,0.624331321,0
1850,10,COMPARTMENTS,,Nuclear lumen,3.48E-06,SKP1|CASP6|CDK2|TP53|CASP3|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35768|35765|35747|35759|35753,3.02E-09,,GOCC:0031981,0.623323567,0
217,5,KEGG Pathways,,Human cytomegalovirus infection,4.32E-06,TP53|CASP3|E2F1|CREB1|CTNNB1,35655,35771|35777|35768|35759|35753,1.29E-07,,hsa05163,0.612600156,0
2902,11,COMPARTMENTS,,Intracellular organelle lumen,5.75E-06,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35765|35747|35759|35753,7.50E-09,,GOCC:0070013,0.59841897,0
507,7,GO Biological Process,,Positive regulation of apoptotic process,6.24E-06,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|CTNNB1,35655,35762|35771|35777|35744|35768|35774|35753,5.57E-09,,GO:0043065,0.594363141,0
49,4,Reactome Pathways,,TP53 Regulates Transcription of Cell Cycle Genes,6.47E-06,CDK2|TP53|E2F1|CDK1,35655,35750|35771|35768|35765,2.27E-08,,HSA-6791312,0.592568033,0
52,4,Reactome Pathways,,Intrinsic Pathway for Apoptosis,7.19E-06,TP53|CASP3|E2F1|TP73,35655,35771|35777|35768|35774,2.84E-08,,HSA-109606,0.587335098,0
8,3,Reactome Pathways,,Activation of PUMA and translocation to mitochondria,7.19E-06,TP53|E2F1|TP73,35655,35771|35768|35774,2.84E-08,,HSA-139915,0.587335098,0
159,5,Reactome Pathways,,Regulation of TP53 Activity,7.19E-06,CDK2|TP53|TP73|CDK1|HIPK2,35655,35750|35771|35774|35765|35747,2.83E-08,,HSA-5633007,0.587335098,0
515,6,KEGG Pathways,,Pathways in cancer,7.75E-06,SKP1|CDK2|TP53|CASP3|E2F1|CTNNB1,35655,35756|35750|35771|35777|35768|35753,2.67E-07,,hsa05200,0.583615451,0
92,4,KEGG Pathways,,Small cell lung cancer,7.75E-06,CDK2|TP53|CASP3|E2F1,35655,35750|35771|35777|35768,2.54E-07,,hsa05222,0.583615451,0
2056,10,GO Biological Process,,Positive regulation of nucleobase-containing compound metabolic process,8.32E-06,CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,8.49E-09,,GO:0045935,0.58009578,0
15,3,WikiPathways,,miRNAs involved in DNA damage response,8.41E-06,TP53|E2F1|CREB1,35655,35771|35768|35759,1.40E-07,,WP1545,0.579562185,0
82,4,WikiPathways,,Glioblastoma signaling pathways,8.66E-06,CDK2|TP53|PRKCD|E2F1,35655,35750|35771|35744|35768,1.63E-07,,WP2261,0.57810941,0
83,4,WikiPathways,,Apoptosis,8.66E-06,CASP6|TP53|CASP3|TP73,35655,35762|35771|35777|35774,1.71E-07,,WP254,0.57810941,0
81,4,WikiPathways,,DNA IR-damage and cellular response via ATR,8.66E-06,CDK2|TP53|E2F1|CDK1,35655,35750|35771|35768|35765,1.55E-07,,WP4016,0.57810941,0
87,4,WikiPathways,,Retinoblastoma gene in cancer,9.40E-06,CDK2|TP53|E2F1|CDK1,35655,35750|35771|35768|35765,2.05E-07,,WP2446,0.574042936,0
8,3,COMPARTMENTS,,PCNA complex,1.09E-05,CDK2|TP53|CASP3,35655,35750|35771|35777,2.84E-08,,GOCC:0043626,0.566700361,0
92,4,WikiPathways,,Corticotropin-releasing hormone signaling pathway,1.10E-05,CASP3|PRKCD|CREB1|CTNNB1,35655,35777|35744|35759|35753,2.54E-07,,WP2355,0.566247443,0
963,8,GO Biological Process,,Response to organonitrogen compound,1.16E-05,CASP6|TP53|CASP3|PRKCD|TP73|CDK1|CREB1|CTNNB1,35655,35762|35771|35777|35744|35774|35765|35759|35753,1.40E-08,,GO:0010243,0.563613504,0
135,5,GO Biological Process,,Signal transduction in response to DNA damage,1.16E-05,CDK2|TP53|E2F1|CDK1|HIPK2,35655,35750|35771|35768|35765|35747,1.28E-08,,GO:0042770,0.563613504,0
1462,9,GO Biological Process,,Regulation of apoptotic process,1.16E-05,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CTNNB1,35655,35762|35771|35777|35744|35768|35774|35765|35747|35753,1.26E-08,,GO:0042981,0.563613504,0
4787,12,COMPARTMENTS,,Nucleus,1.23E-05,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,4.29E-08,,GOCC:0005634,0.560707574,0
197,5,Reactome Pathways,,Mitotic G2-G2/M phases,1.37E-05,SKP1|CDK2|TP53|E2F1|CDK1,35655,35756|35750|35771|35768|35765,8.04E-08,,HSA-453274,0.55536149,0
12,3,Reactome Pathways,,TP53 Regulates Transcription of Caspase Activators and Caspases,1.37E-05,CASP6|TP53|TP73,35655,35762|35771|35774,7.81E-08,,HSA-6803207,0.55536149,0
4169,12,GO Cellular Component,,Nucleoplasm,1.68E-05,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,8.19E-09,,GO:0005654,0.545245114,0
14,3,Reactome Pathways,,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1.78E-05,CDK2|TP53|E2F1,35655,35750|35771|35768,1.17E-07,,HSA-6804116,0.542377599,0
113,4,WikiPathways,,Gastrin signaling pathway,2.31E-05,CASP3|PRKCD|CREB1|CTNNB1,35655,35777|35744|35759|35753,5.63E-07,,WP4659,0.529451658,0
359,6,GO Biological Process,,Negative regulation of cell cycle,2.32E-05,CDK2|TP53|CASP3|E2F1|CDK1|CTNNB1,35655,35750|35771|35777|35768|35765|35753,3.26E-08,,GO:0045786,0.529237427,0
1108,8,GO Biological Process,,Regulation of cell cycle,2.72E-05,CDK2|TP53|CASP3|E2F1|TP73|CDK1|HIPK2|CTNNB1,35655,35750|35771|35777|35768|35774|35765|35747|35753,4.16E-08,,GO:0051726,0.521348742,0
137,4,KEGG Pathways,,Measles,3.07E-05,CDK2|TP53|CASP3|TP73,35655,35750|35771|35777|35774,1.19E-06,,hsa05162,0.515345579,0
146,4,KEGG Pathways,,Gastric cancer,3.65E-05,CDK2|TP53|E2F1|CTNNB1,35655,35750|35771|35768|35753,1.52E-06,,hsa05226,0.506763323,0
153,4,KEGG Pathways,,Cushing syndrome,4.09E-05,CDK2|E2F1|CREB1|CTNNB1,35655,35750|35768|35759|35753,1.82E-06,,hsa04934,0.50111862,0
322,6,TISSUES,,Cervical carcinoma cell,4.18E-05,CDK2|CASP3|E2F1|CDK1|CREB1|CTNNB1,35655,35750|35777|35768|35765|35759|35753,1.72E-08,,BTO:0000180,0.500039139,0
135,4,WikiPathways,,Measles virus infection,4.38E-05,CDK2|TP53|CASP3|TP73,35655,35750|35771|35777|35774,1.12E-06,,WP4630,0.497721232,0
744,7,GO Biological Process,,Cellular response to DNA damage stimulus,4.77E-05,CDK2|TP53|CASP3|E2F1|TP73|CDK1|HIPK2,35655,35750|35771|35777|35768|35774|35765|35747,7.60E-08,,GO:0006974,0.493490967,0
2609,10,GO Biological Process,,Cellular response to chemical stimulus,5.21E-05,CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35750|35771|35777|35744|35768|35765|35747|35759|35753,8.63E-08,,GO:0070887,0.489115095,0
143,4,WikiPathways,,Brain-derived neurotrophic factor (BDNF) signaling pathway,5.22E-05,CASP3|PRKCD|CREB1|CTNNB1,35655,35777|35744|35759|35753,1.40E-06,,WP2380,0.489019996,0
154,4,WikiPathways,,Breast cancer pathway,6.64E-05,SKP1|TP53|E2F1|CTNNB1,35655,35756|35771|35768|35753,1.87E-06,,WP4262,0.47708691,0
154,4,WikiPathways,,Sudden infant death syndrome (SIDS) susceptibility pathways,6.64E-05,CASP3|TP73|CREB1|CTNNB1,35655,35777|35774|35759|35753,1.87E-06,,WP706,0.47708691,0
75,4,GO Biological Process,,Intrinsic apoptotic signaling pathway in response to DNA damage,6.71E-05,TP53|E2F1|TP73|HIPK2,35655,35771|35768|35774|35747,1.15E-07,,GO:0008630,0.476566817,0
2692,10,GO Biological Process,,Response to organic substance,6.71E-05,CASP6|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35771|35777|35744|35768|35774|35765|35747|35759|35753,1.17E-07,,GO:0010033,0.476566817,0
473,6,GO Biological Process,,Cellular response to growth factor stimulus,8.81E-05,TP53|CASP3|E2F1|HIPK2|CREB1|CTNNB1,35655,35771|35777|35768|35747|35759|35753,1.63E-07,,GO:0071363,0.463062888,0
192,4,KEGG Pathways,,Epstein-Barr virus infection,9.26E-05,CDK2|TP53|CASP3|E2F1,35655,35750|35771|35777|35768,4.41E-06,,hsa05169,0.460592273,0
419,6,TISSUES,,Lymphocytic leukemia cell,9.74E-05,CDK2|TP53|E2F1|CDK1|CREB1|CTNNB1,35655,35750|35771|35768|35765|35759|35753,8.03E-08,,BTO:0000744,0.458085928,0
27,3,Reactome Pathways,,G0 and Early G1,9.89E-05,CDK2|E2F1|CDK1,35655,35750|35768|35765,6.93E-07,,HSA-1538133,0.457327979,0
493,6,GO Biological Process,,Regulation of mitotic cell cycle,1.10E-04,CDK2|TP53|E2F1|TP73|CDK1|CTNNB1,35655,35750|35771|35768|35774|35765|35753,2.07E-07,,GO:0007346,0.452052588,0
1363,8,GO Biological Process,,Response to endogenous stimulus,1.10E-04,CASP6|TP53|CASP3|PRKCD|E2F1|HIPK2|CREB1|CTNNB1,35655,35762|35771|35777|35744|35768|35747|35759|35753,2.06E-07,,GO:0009719,0.452052588,0
4010,11,GO Biological Process,,Response to chemical,1.10E-04,CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,2.46E-07,,GO:0042221,0.452052588,0
2019,9,GO Biological Process,,Cellular response to organic substance,1.10E-04,CASP6|TP53|CASP3|PRKCD|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35771|35777|35744|35768|35765|35747|35759|35753,2.09E-07,,GO:0071310,0.452052588,0
222,5,TISSUES,,Chronic lymphocytic leukemia cell,1.20E-04,CDK2|E2F1|CDK1|CREB1|CTNNB1,35655,35750|35768|35765|35759|35753,1.44E-07,,BTO:0001546,0.447737329,0
210,4,KEGG Pathways,,Human T-cell leukemia virus 1 infection,1.20E-04,CDK2|TP53|E2F1|CREB1,35655,35750|35771|35768|35759,6.25E-06,,hsa05166,0.447737329,0
130,4,Reactome Pathways,,G1/S Transition,1.20E-04,SKP1|CDK2|E2F1|CDK1,35655,35756|35750|35768|35765,9.69E-07,,HSA-69206,0.447737329,0
434,5,WikiPathways,,Malignant pleural mesothelioma,1.20E-04,CDK2|TP53|E2F1|CREB1|CTNNB1,35655,35750|35771|35768|35759|35753,3.73E-06,,WP5087,0.447737329,0
49,3,WikiPathways,,TROP2 regulatory signaling,1.20E-04,CDK2|PRKCD|CTNNB1,35655,35750|35744|35753,3.75E-06,,WP5300,0.447737329,0
101,4,GO Biological Process,,Regulation of gliogenesis,1.60E-04,TP53|E2F1|TP73|CTNNB1,35655,35771|35768|35774|35753,3.64E-07,,GO:0014013,0.433469968,0
541,6,GO Biological Process,,Regulation of DNA metabolic process,1.60E-04,CDK2|TP53|CASP3|PRKCD|CDK1|CTNNB1,35655,35750|35771|35777|35744|35765|35753,3.56E-07,,GO:0051052,0.433469968,0
105,4,GO Biological Process,,DNA damage checkpoint signaling,1.70E-04,CDK2|TP53|E2F1|CDK1,35655,35750|35771|35768|35765,4.23E-07,,GO:0000077,0.430463339,0
5781,12,GO Biological Process,,Macromolecule metabolic process,1.70E-04,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,4.12E-07,,GO:0043170,0.430463339,0
2540,9,Reactome Pathways,,Signal Transduction,1.70E-04,SKP1|CDK2|TP53|CASP3|PRKCD|E2F1|CDK1|CREB1|CTNNB1,35655,35756|35750|35771|35777|35744|35768|35765|35759|35753,1.52E-06,,HSA-162582,0.430463339,0
35,3,Reactome Pathways,,Regulation of TP53 Degradation,1.70E-04,CDK2|TP53|CDK1,35655,35750|35771|35765,1.44E-06,,HSA-6804757,0.430463339,0
517,6,GO Cellular Component,,Transcription regulator complex,1.90E-04,CDK2|TP53|E2F1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35768|35747|35759|35753,2.74E-07,,GO:0005667,0.424947193,0
5899,12,GO Biological Process,,Regulation of primary metabolic process,2.00E-04,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,5.25E-07,,GO:0080090,0.422403343,0
1547,8,GO Biological Process,,Response to oxygen-containing compound,2.00E-04,CDK2|TP53|CASP3|PRKCD|E2F1|CDK1|CREB1|CTNNB1,35655,35750|35771|35777|35744|35768|35765|35759|35753,5.47E-07,,GO:1901700,0.422403343,0
609,6,GO Cellular Component,,Centrosome,2.10E-04,SKP1|CDK2|TP53|E2F1|CDK1|CTNNB1,35655,35756|35750|35771|35768|35765|35753,7.09E-07,,GO:0005813,0.419983634,0
1572,8,GO Biological Process,,Cellular response to stress,2.20E-04,CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2,35655,35750|35771|35777|35744|35768|35774|35765|35747,6.19E-07,,GO:0033554,0.417676512,0
62,3,WikiPathways,,DYRK1A,2.20E-04,TP53|CASP3|CREB1,35655,35771|35777|35759,7.37E-06,,WP5180,0.417676512,0
304,5,GO Biological Process,,Positive regulation of DNA metabolic process,2.30E-04,CDK2|CASP3|PRKCD|CDK1|CTNNB1,35655,35750|35777|35744|35765|35753,6.63E-07,,GO:0051054,0.415471962,0
651,6,UniProt Keywords,,Cell cycle,2.30E-04,CDK2|TP53|PRKCD|E2F1|TP73|CDK1,35655,35750|35771|35744|35768|35774|35765,1.04E-06,,KW-0131,0.415471962,0
747,6,Reactome Pathways,,Cellular responses to stress,2.30E-04,SKP1|CDK2|TP53|PRKCD|E2F1|CREB1,35655,35756|35750|35771|35744|35768|35759,2.31E-06,,HSA-2262752,0.415471962,0
66,3,WikiPathways,,Thyroid stimulating hormone (TSH) signaling pathway,2.60E-04,CDK2|E2F1|CREB1,35655,35750|35768|35759,8.83E-06,,WP2032,0.409391599,0
68,3,WikiPathways,,Melanoma,2.70E-04,TP53|E2F1|CREB1,35655,35771|35768|35759,9.63E-06,,WP4685,0.407519897,0
1057,7,GO Biological Process,,Cellular response to oxygen-containing compound,2.80E-04,CDK2|TP53|PRKCD|E2F1|CDK1|CREB1|CTNNB1,35655,35750|35771|35744|35768|35765|35759|35753,8.17E-07,,GO:1901701,0.405716273,0
47,3,Reactome Pathways,,Cyclin D associated events in G1,2.90E-04,SKP1|CDK2|E2F1,35655,35756|35750|35768,3.32E-06,,HSA-69231,0.403975948,0
637,6,GO Biological Process,,Cellular response to nitrogen compound,3.10E-04,CASP6|CDK2|TP53|CASP3|PRKCD|CTNNB1,35655,35762|35750|35771|35777|35744|35753,9.20E-07,,GO:1901699,0.400668443,0
82,3,KEGG Pathways,,Colorectal cancer,3.10E-04,TP53|CASP3|CTNNB1,35655,35771|35777|35753,1.66E-05,,hsa05210,0.400668443,0
72,3,WikiPathways,,Chromosomal and microsatellite instability in colorectal cancer ,3.10E-04,TP53|CASP3|CTNNB1,35655,35771|35777|35753,1.14E-05,,WP4216,0.400668443,0
72,3,WikiPathways,,Non-small cell lung cancer,3.10E-04,TP53|CASP3|E2F1,35655,35771|35777|35768,1.14E-05,,WP4255,0.400668443,0
72,3,WikiPathways,,Head and neck squamous cell carcinoma,3.10E-04,TP53|E2F1|CTNNB1,35655,35771|35768|35753,1.14E-05,,WP4674,0.400668443,0
1669,8,GO Biological Process,,Regulation of cell population proliferation,3.20E-04,CDK2|TP53|CASP3|E2F1|TP73|CDK1|HIPK2|CTNNB1,35655,35750|35771|35777|35768|35774|35765|35747|35753,9.79E-07,,GO:0042127,0.399093891,0
1103,7,GO Biological Process,,Cellular response to endogenous stimulus,3.30E-04,CASP6|TP53|CASP3|PRKCD|E2F1|HIPK2|CTNNB1,35655,35762|35771|35777|35744|35768|35747|35753,1.09E-06,,GO:0071495,0.397567796,0
32,3,GO Biological Process,,Intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,3.40E-04,TP53|TP73|HIPK2,35655,35771|35774|35747,1.12E-06,,GO:0042771,0.396087262,0
195,4,Reactome Pathways,,G2/M Transition,3.80E-04,SKP1|CDK2|TP53|CDK1,35655,35756|35750|35771|35765,4.68E-06,,HSA-69275,0.390571116,0
271,4,WikiPathways,,IL-18 signaling pathway,4.10E-04,TP53|CASP3|PRKCD|CTNNB1,35655,35771|35777|35744|35753,1.68E-05,,WP4754,0.386802656,0
1067,7,TISSUES,,Leukemia cell,4.20E-04,CDK2|TP53|CASP3|E2F1|CDK1|CREB1|CTNNB1,35655,35750|35771|35777|35768|35765|35759|35753,8.70E-07,,BTO:0001271,0.385607558,0
27,3,TISSUES,,Colonic adenocarcinoma cell line,4.20E-04,TP53|CASP3|CTNNB1,35655,35771|35777|35753,6.93E-07,,BTO:0001913,0.385607558,0
85,3,WikiPathways,,Acute viral myocarditis,4.30E-04,CASP6|CASP3|CREB1,35655,35762|35777|35759,1.84E-05,,WP4298,0.384440581,0
204,4,Reactome Pathways,,Signaling by NOTCH,4.40E-04,SKP1|TP53|E2F1|CREB1,35655,35756|35771|35768|35759,5.58E-06,,HSA-157118,0.383300435,0
86,3,WikiPathways,,Pancreatic adenocarcinoma pathway,4.40E-04,TP53|PRKCD|E2F1,35655,35771|35744|35768,1.90E-05,,WP4263,0.383300435,0
3,2,TISSUES,,DLD-1 cell,4.60E-04,TP53|CTNNB1,35655,35771|35753,3.39E-06,,BTO:0000391,0.381095885,0
40,3,TISSUES,,Intestinal epithelium,4.60E-04,TP53|CDK1|CTNNB1,35655,35771|35765|35753,2.10E-06,,BTO:0000781,0.381095885,0
2,2,TISSUES,,HEP-3B cell,4.60E-04,TP53|CASP3,35655,35771|35777,2.04E-06,,BTO:0000972,0.381095885,0
1151,7,TISSUES,,Skin,4.60E-04,SKP1|TP53|PRKCD|E2F1|TP73|CDK1|CTNNB1,35655,35756|35771|35744|35768|35774|35765|35753,1.45E-06,,BTO:0001253,0.381095885,0
2,2,TISSUES,,HCT-15 cell,4.60E-04,TP53|CASP3,35655,35771|35777,2.04E-06,,BTO:0002201,0.381095885,0
3,2,TISSUES,,NCI-H460 cell,4.60E-04,TP53|CASP3,35655,35771|35777,3.39E-06,,BTO:0002207,0.381095885,0
89,3,WikiPathways,,Apoptosis modulation and signaling,4.70E-04,CASP6|TP53|CASP3,35655,35762|35771|35777,2.10E-05,,WP1772,0.380029302,0
10,2,WikiPathways,,Mammary gland development pathway - Involution (Stage 4 of 4),4.80E-04,TP53|E2F1,35655,35771|35768,2.23E-05,,WP2815,0.378985176,0
59,3,Reactome Pathways,,Transcriptional regulation of granulopoiesis,4.90E-04,CDK2|E2F1|CREB1,35655,35750|35768|35759,6.39E-06,,HSA-9616222,0.377962579,0
5,2,Reactome Pathways,,Activation of NOXA and translocation to mitochondria,5.20E-04,TP53|E2F1,35655,35771|35768,7.12E-06,,HSA-111448,0.375015522,0
5,2,Reactome Pathways,,G2 Phase,5.20E-04,CDK2|E2F1,35655,35750|35768,7.12E-06,,HSA-68911,0.375015522,0
18,3,STRING Clusters,,"Mixed, incl. P53 DNA-binding domain, and SWIB/MDM2 domain",5.20E-04,TP53|TP73|HIPK2,35655,35771|35774|35747,2.28E-07,,CL:6995,0.375015522,0
4,2,TISSUES,,SW-480 cell,5.60E-04,TP53|CTNNB1,35655,35771|35753,5.09E-06,,BTO:0000038,0.371340197,0
6643,12,GO Biological Process,,Nitrogen compound metabolic process,6.20E-04,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,2.18E-06,,GO:0006807,0.366292366,0
100,3,WikiPathways,,Wnt signaling pathway and pluripotency,6.20E-04,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,2.95E-05,,WP399,0.366292366,0
1246,7,GO Biological Process,,Cell cycle,6.90E-04,CDK2|TP53|PRKCD|E2F1|TP73|CDK1|CTNNB1,35655,35750|35771|35744|35768|35774|35765|35753,2.46E-06,,GO:0007049,0.36098717,0
112,3,KEGG Pathways,,Neurotrophin signaling pathway,7.20E-04,TP53|PRKCD|TP73,35655,35771|35744|35774,4.10E-05,,hsa04722,0.35887646,0
5,2,TISSUES,,HT-29 cell,7.50E-04,TP53|CASP3,35655,35771|35777,7.12E-06,,BTO:0000182,0.356851926,0
5,2,TISSUES,,Vas efferens,7.50E-04,TP53|CASP3,35655,35771|35777,7.12E-06,,BTO:0002254,0.356851926,0
5,2,TISSUES,,M cell,7.50E-04,TP53|CDK1,35655,35771|35765,7.12E-06,,BTO:0003600,0.356851926,0
978,7,DISEASES,,Cancer,7.60E-04,CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CTNNB1,35655,35750|35771|35777|35744|35768|35774|35753,4.84E-07,,DOID:162,0.356195039,0
21,3,DISEASES,,Liver cancer,7.60E-04,TP53|CASP3|CTNNB1,35655,35771|35777|35753,3.46E-07,,DOID:3571,0.356195039,0
16,3,DISEASES,,Retinoblastoma,7.60E-04,CDK2|TP53|E2F1,35655,35750|35771|35768,1.66E-07,,DOID:768,0.356195039,0
109,3,WikiPathways,,DNA damage response (only ATM dependent),7.80E-04,TP53|TP73|CTNNB1,35655,35771|35774|35753,3.78E-05,,WP710,0.354906806,0
14,2,WikiPathways,,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,8.10E-04,E2F1|CTNNB1,35655,35768|35753,4.06E-05,,WP3969,0.353035105,0
2760,9,GO Biological Process,,Negative regulation of macromolecule metabolic process,8.20E-04,CDK2|TP53|CASP3|PRKCD|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35777|35744|35768|35765|35747|35759|35753,3.10E-06,,GO:0010605,0.35242658,0
789,6,GO Biological Process,,Regulation of cellular catabolic process,8.30E-04,CDK2|TP53|CASP3|PRKCD|E2F1|HIPK2,35655,35750|35771|35777|35744|35768|35747,3.17E-06,,GO:0031329,0.35182543,0
121,3,KEGG Pathways,,Oocyte meiosis,8.60E-04,SKP1|CDK2|CDK1,35655,35756|35750|35765,5.13E-05,,hsa04114,0.350064505,0
6,2,TISSUES,,HeLa cell,8.90E-04,TP53|CASP3,35655,35771|35777,9.49E-06,,BTO:0000567,0.348363966,0
15,2,WikiPathways,,ERK pathway in Huntingtons disease,9.00E-04,CASP3|CREB1,35655,35777|35759,4.60E-05,,WP3853,0.347809835,0
484,6,GO Molecular Function,,DNA-binding transcription factor binding,9.20E-04,TP53|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35771|35768|35774|35747|35759|35753,1.86E-07,,GO:0140297,0.346719809,0
56,3,UniProt Keywords,,S-nitrosylation,9.20E-04,CDK2|CASP3|CTNNB1,35655,35750|35777|35753,5.50E-06,,KW-0702,0.346719809,0
131,3,KEGG Pathways,,Apoptosis,0.001,CASP6|TP53|CASP3,35655,35762|35771|35777,6.46E-05,,hsa04210,0.342584565,0
80,3,Reactome Pathways,,Regulation of APC/C activators between G1/S and early anaphase,0.001,SKP1|CDK2|CDK1,35655,35756|35750|35765,1.54E-05,,HSA-176408,0.342584565,0
193,4,GO Biological Process,,Peptidyl-serine phosphorylation,0.0011,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,4.50E-06,,GO:0018105,0.337857733,0
2041,8,GO Biological Process,,Positive regulation of cellular biosynthetic process,0.0011,CDK2|TP53|PRKCD|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35750|35771|35744|35768|35774|35747|35759|35753,4.53E-06,,GO:0031328,0.337857733,0
52,3,GO Biological Process,,Epithelial cell apoptotic process,0.0011,CASP6|CASP3|E2F1,35655,35762|35777|35768,4.44E-06,,GO:1904019,0.337857733,0
7,2,TISSUES,,A-549 cell,0.0011,TP53|CASP3,35655,35771|35777,1.22E-05,,BTO:0000018,0.337857733,0
7,2,TISSUES,,Hep-G2 cell,0.0011,TP53|CASP3,35655,35771|35777,1.22E-05,,BTO:0000599,0.337857733,0
7,2,TISSUES,,Colorectal cancer cell,0.0011,TP53|CTNNB1,35655,35771|35753,1.22E-05,,BTO:0001615,0.337857733,0
82,3,Reactome Pathways,,Cyclin E associated events during G1/S transition,0.0011,SKP1|CDK2|E2F1,35655,35756|35750|35768,1.66E-05,,HSA-69202,0.337857733,0
84,3,Reactome Pathways,,Cyclin A:Cdk2-associated events at S phase entry,0.0011,SKP1|CDK2|E2F1,35655,35756|35750|35768,1.78E-05,,HSA-69656,0.337857733,0
27,3,STRING Clusters,,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3), and Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes",0.0011,CDK2|E2F1|CDK1,35655,35750|35768|35765,6.93E-07,,CL:6903,0.337857733,0
54,3,GO Biological Process,,Positive regulation of neuron apoptotic process,0.0012,TP53|CASP3|CTNNB1,35655,35771|35777|35753,4.95E-06,,GO:0043525,0.333542474,0
7156,12,GO Biological Process,,Primary metabolic process,0.0012,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,5.32E-06,,GO:0044238,0.333542474,0
1389,7,GO Biological Process,,Regulation of multicellular organismal development,0.0012,TP53|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35771|35768|35774|35765|35747|35759|35753,5.08E-06,,GO:2000026,0.333542474,0
130,3,WikiPathways,,Adipogenesis,0.0012,E2F1|CREB1|CTNNB1,35655,35768|35759|35753,6.32E-05,,WP236,0.333542474,0
132,3,WikiPathways,,TGF-beta signaling pathway,0.0012,SKP1|TP53|CDK1,35655,35756|35771|35765,6.61E-05,,WP366,0.333542474,0
18,2,WikiPathways,,Apoptosis modulation by HSP70,0.0012,CASP6|CASP3,35655,35762|35777,6.42E-05,,WP384,0.333542474,0
19,2,WikiPathways,,TP53 network,0.0013,TP53|TP73,35655,35771|35774,7.09E-05,,WP1742,0.32957282,0
470,5,COMPARTMENTS,,Centrosome,0.0014,CDK2|TP53|E2F1|CDK1|CTNNB1,35655,35750|35771|35768|35765|35753,5.48E-06,,GOCC:0005813,0.325897495,0
891,6,GO Biological Process,,Negative regulation of apoptotic process,0.0014,TP53|CASP3|PRKCD|CDK1|HIPK2|CTNNB1,35655,35771|35777|35744|35765|35747|35753,6.37E-06,,GO:0043066,0.325897495,0
146,3,KEGG Pathways,,Breast cancer,0.0014,TP53|E2F1|CTNNB1,35655,35771|35768|35753,8.86E-05,,hsa05224,0.325897495,0
100,3,Reactome Pathways,,Toll Like Receptor 3 (TLR3) Cascade,0.0014,SKP1|TP53|CREB1,35655,35756|35771|35759,2.95E-05,,HSA-168164,0.325897495,0
12,2,Reactome Pathways,,Caspase-mediated cleavage of cytoskeletal proteins,0.0014,CASP6|CASP3,35655,35762|35777,3.08E-05,,HSA-264870,0.325897495,0
11,2,Reactome Pathways,,Apoptotic cleavage of cell adhesion  proteins,0.0014,CASP3|CTNNB1,35655,35777|35753,2.64E-05,,HSA-351906,0.325897495,0
12,2,Reactome Pathways,,TP53 Regulates Transcription of Death Receptors and Ligands,0.0014,TP53|TP73,35655,35771|35774,3.08E-05,,HSA-6803211,0.325897495,0
92,3,Reactome Pathways,,Regulation of TP53 Activity through Phosphorylation,0.0014,CDK2|TP53|HIPK2,35655,35750|35771|35747,2.31E-05,,HSA-6804756,0.325897495,0
104,3,Reactome Pathways,,TRIF(TICAM1)-mediated TLR4 signaling,0.0014,SKP1|TP53|CREB1,35655,35756|35771|35759,3.30E-05,,HSA-937061,0.325897495,0
98,3,Reactome Pathways,,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,0.0014,SKP1|TP53|CREB1,35655,35756|35771|35759,2.78E-05,,HSA-975138,0.325897495,0
93,3,Reactome Pathways,,MyD88 cascade initiated on plasma membrane,0.0014,SKP1|TP53|CREB1,35655,35756|35771|35759,2.39E-05,,HSA-975871,0.325897495,0
20,2,WikiPathways,,Nanomaterial induced apoptosis,0.0014,CASP6|CASP3,35655,35762|35777,7.80E-05,,WP2507,0.325897495,0
20,2,WikiPathways,,Galanin receptor pathway,0.0014,PRKCD|CREB1,35655,35744|35759,7.80E-05,,WP4970,0.325897495,0
5,2,GO Biological Process,,Glial cell apoptotic process,0.0015,TP53|CASP3,35655,35771|35777,7.12E-06,,GO:0034349,0.322475849,0
216,4,GO Biological Process,,Regulation of neuron apoptotic process,0.0015,TP53|CASP3|HIPK2|CTNNB1,35655,35771|35777|35747|35753,6.97E-06,,GO:0043523,0.322475849,0
214,4,GO Biological Process,,Negative regulation of mitotic cell cycle,0.0015,CDK2|TP53|CDK1|CTNNB1,35655,35750|35771|35765|35753,6.72E-06,,GO:0045930,0.322475849,0
5,2,GO Biological Process,,Positive regulation of programmed necrotic cell death,0.0015,CASP6|TP53,35655,35762|35771,7.12E-06,,GO:0062100,0.322475849,0
508,5,GO Biological Process,,Cellular response to organic cyclic compound,0.0015,CASP6|CASP3|CDK1|CREB1|CTNNB1,35655,35762|35777|35765|35759|35753,7.97E-06,,GO:0071407,0.322475849,0
5,2,GO Biological Process,,Cellular response to staurosporine,0.0015,CASP6|CASP3,35655,35762|35777,7.12E-06,,GO:0072734,0.322475849,0
60,3,GO Biological Process,,Cellular senescence,0.0015,CDK2|TP53|PRKCD,35655,35750|35771|35744,6.71E-06,,GO:0090398,0.322475849,0
9,2,TISSUES,,MDA-MB-231 cell,0.0015,TP53|CASP3,35655,35771|35777,1.86E-05,,BTO:0000815,0.322475849,0
154,3,KEGG Pathways,,Wnt signaling pathway,0.0015,SKP1|TP53|CTNNB1,35655,35756|35771|35753,1.00E-04,,hsa04310,0.322475849,0
518,5,GO Biological Process,,"Transcription, DNA-templated",0.0016,CDK2|TP53|E2F1|CREB1|CTNNB1,35655,35750|35771|35768|35759|35753,8.76E-06,,GO:0006351,0.319275113,0
5584,11,GO Biological Process,,Positive regulation of cellular process,0.0016,CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,8.50E-06,,GO:0048522,0.319275113,0
1512,7,GO Biological Process,,Positive regulation of protein metabolic process,0.0016,SKP1|CASP6|TP53|CASP3|PRKCD|HIPK2|CTNNB1,35655,35756|35762|35771|35777|35744|35747|35753,8.92E-06,,GO:0051247,0.319275113,0
159,3,KEGG Pathways,,MicroRNAs in cancer,0.0016,TP53|CASP3|E2F1,35655,35771|35777|35768,1.10E-04,,hsa05206,0.319275113,0
161,3,KEGG Pathways,,Hepatocellular carcinoma,0.0016,TP53|E2F1|CTNNB1,35655,35771|35768|35753,1.20E-04,,hsa05225,0.319275113,0
706,5,Reactome Pathways,,Cytokine Signaling in Immune system,0.0016,SKP1|TP53|CASP3|PRKCD|CREB1,35655,35756|35771|35777|35744|35759,3.86E-05,,HSA-1280215,0.319275113,0
109,3,Reactome Pathways,,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,0.0016,SKP1|TP53|CREB1,35655,35756|35771|35759,3.78E-05,,HSA-166058,0.319275113,0
14,2,Reactome Pathways,,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,0.0016,TP53|TP73,35655,35771|35774,4.06E-05,,HSA-6803205,0.319275113,0
14,2,Reactome Pathways,,Regulation of TP53 Activity through Association with Co-factors,0.0016,TP53|TP73,35655,35771|35774,4.06E-05,,HSA-6804759,0.319275113,0
532,5,GO Biological Process,,Response to inorganic substance,0.0018,CDK2|CASP3|PRKCD|CDK1|CREB1,35655,35750|35777|35744|35765|35759,9.96E-06,,GO:0010035,0.313433758,0
2265,8,GO Biological Process,,Negative regulation of cellular metabolic process,0.0018,CDK2|TP53|CASP3|PRKCD|E2F1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35777|35744|35768|35747|35759|35753,9.96E-06,,GO:0031324,0.313433758,0
24,2,WikiPathways,,miRNA regulation of p53 pathway in prostate cancer,0.0018,TP53|CASP3,35655,35771|35777,1.10E-04,,WP3982,0.313433758,0
11,2,TISSUES,,MCF-7 cell,0.0019,TP53|CASP3,35655,35771|35777,2.64E-05,,BTO:0000093,0.310752338,0
16,2,Reactome Pathways,,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,0.0019,E2F1|CDK1,35655,35768|35765,5.17E-05,,HSA-1362300,0.310752338,0
162,3,WikiPathways,,EGF/EGFR signaling pathway,0.002,PRKCD|E2F1|CREB1,35655,35744|35768|35759,1.20E-04,,WP437,0.308208488,0
74,3,GO Biological Process,,Regulation of glial cell differentiation,0.0021,TP73|CDK1|CTNNB1,35655,35774|35765|35753,1.23E-05,,GO:0045685,0.305788779,0
1824,7,TISSUES,,Blood,0.0021,SKP1|CASP6|TP53|CASP3|PRKCD|TP73|CDK1,35655,35756|35762|35771|35777|35744|35774|35765,3.07E-05,,BTO:0000089,0.305788779,0
17,2,Reactome Pathways,,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.0021,CDK2|E2F1,35655,35750|35768,5.78E-05,,HSA-9661069,0.305788779,0
30,2,KEGG Pathways,,Circadian rhythm,0.0022,SKP1|CREB1,35655,35756|35759,1.70E-04,,hsa04710,0.303481657,0
353,5,GO Molecular Function,,RNA polymerase II-specific DNA-binding transcription factor binding,0.0023,TP53|TP73|HIPK2|CREB1|CTNNB1,35655,35771|35774|35747|35759|35753,1.37E-06,,GO:0061629,0.301277107,0
18,2,Reactome Pathways,,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,0.0023,TP53|CDK1,35655,35771|35765,6.42E-05,,HSA-6804114,0.301277107,0
28,2,WikiPathways,,Sphingolipid metabolism in senescence,0.0023,CDK2|E2F1,35655,35750|35768,1.50E-04,,WP5121,0.301277107,0
78,3,GO Biological Process,,Peptidyl-threonine phosphorylation,0.0024,PRKCD|CDK1|HIPK2,35655,35744|35765|35747,1.43E-05,,GO:0018107,0.299166397,0
263,4,GO Biological Process,,Myeloid cell differentiation,0.0024,CASP3|HIPK2|CREB1|CTNNB1,35655,35777|35747|35759|35753,1.50E-05,,GO:0030099,0.299166397,0
574,5,GO Biological Process,,Cellular response to organonitrogen compound,0.0024,CASP6|TP53|CASP3|PRKCD|CTNNB1,35655,35762|35771|35777|35744|35753,1.43E-05,,GO:0071417,0.299166397,0
2403,8,GO Biological Process,,Negative regulation of nitrogen compound metabolic process,0.0025,CDK2|TP53|CASP3|PRKCD|E2F1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35777|35744|35768|35747|35759|35753,1.55E-05,,GO:0051172,0.297141863,0
194,3,KEGG Pathways,,Proteoglycans in cancer,0.0025,TP53|CASP3|CTNNB1,35655,35771|35777|35753,2.00E-04,,hsa05205,0.297141863,0
19,2,Reactome Pathways,,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,0.0025,TP53|TP73,35655,35771|35774,7.09E-05,,HSA-6803204,0.297141863,0
81,3,GO Biological Process,,Mitotic DNA damage checkpoint signaling,0.0026,CDK2|TP53|CDK1,35655,35750|35771|35765,1.60E-05,,GO:0044773,0.295196744,0
270,4,GO Biological Process,,Rhythmic process,0.0026,TP53|CASP3|CDK1|CREB1,35655,35771|35777|35765|35759,1.66E-05,,GO:0048511,0.295196744,0
272,4,GO Biological Process,,Cellular response to chemical stress,0.0027,TP53|CASP3|PRKCD|CDK1,35655,35771|35777|35744|35765,1.70E-05,,GO:0062197,0.293325042,0
278,4,GO Biological Process,,Response to hypoxia,0.0028,TP53|CASP3|E2F1|HIPK2,35655,35771|35777|35768|35747,1.85E-05,,GO:0001666,0.291521418,0
1069,6,GO Biological Process,,Epithelium development,0.0028,CASP6|TP53|CASP3|CDK1|CREB1|CTNNB1,35655,35762|35771|35777|35765|35759|35753,1.80E-05,,GO:0060429,0.291521418,0
256,4,GO Cellular Component,,RNA polymerase II transcription regulator complex,0.0028,E2F1|HIPK2|CREB1|CTNNB1,35655,35768|35747|35759|35753,1.35E-05,,GO:0090575,0.291521418,0
203,3,KEGG Pathways,,Human immunodeficiency virus 1 infection,0.0028,SKP1|CASP3|CDK1,35655,35756|35777|35765,2.30E-04,,hsa05170,0.291521418,0
31,2,WikiPathways,,Gastric cancer network 2,0.0028,TP53|CTNNB1,35655,35771|35753,1.80E-04,,WP2363,0.291521418,0
31,2,WikiPathways,,miRNA regulation of prostate cancer signaling pathways,0.0028,TP53|CTNNB1,35655,35771|35753,1.80E-04,,WP3981,0.291521418,0
32,2,WikiPathways,,Prion disease pathway,0.0028,CASP3|CREB1,35655,35777|35759,1.90E-04,,WP3995,0.291521418,0
88,3,GO Biological Process,,Centrosome cycle,0.0029,CDK2|CDK1|CTNNB1,35655,35750|35765|35753,2.03E-05,,GO:0007098,0.289781093,0
617,5,GO Biological Process,,Epithelial cell differentiation,0.0029,CASP6|CASP3|CDK1|CREB1|CTNNB1,35655,35762|35777|35765|35759|35753,2.03E-05,,GO:0030855,0.289781093,0
1710,7,GO Biological Process,,"Positive regulation of transcription, DNA-templated",0.0029,CDK2|TP53|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35750|35771|35768|35774|35747|35759|35753,2.01E-05,,GO:0045893,0.289781093,0
89,3,GO Biological Process,,Regulation of fibroblast proliferation,0.0029,TP53|E2F1|CTNNB1,35655,35771|35768|35753,2.10E-05,,GO:0048145,0.289781093,0
209,3,KEGG Pathways,,Salmonella infection,0.0029,SKP1|CASP3|CTNNB1,35655,35756|35777|35753,2.50E-04,,hsa05132,0.289781093,0
37,2,KEGG Pathways,,Thyroid cancer,0.0029,TP53|CTNNB1,35655,35771|35753,2.50E-04,,hsa05216,0.289781093,0
1107,6,GO Biological Process,,Response to abiotic stimulus,0.0031,TP53|CASP3|PRKCD|E2F1|HIPK2|CTNNB1,35655,35771|35777|35744|35768|35747|35753,2.20E-05,,GO:0009628,0.286473588,0
91,3,GO Biological Process,,Neuron apoptotic process,0.0031,TP53|CASP3|HIPK2,35655,35771|35777|35747,2.24E-05,,GO:0051402,0.286473588,0
218,3,KEGG Pathways,,Shigellosis,0.0031,SKP1|TP53|PRKCD,35655,35756|35771|35744,2.80E-04,,hsa05131,0.286473588,0
40,2,KEGG Pathways,,Bladder cancer,0.0031,TP53|E2F1,35655,35771|35768,2.90E-04,,hsa05219,0.286473588,0
22,2,Reactome Pathways,,E2F mediated regulation of DNA replication,0.0032,E2F1|CDK1,35655,35768|35765,9.31E-05,,HSA-113510,0.284899036,0
149,3,Reactome Pathways,,G2/M Checkpoints,0.0032,CDK2|TP53|CDK1,35655,35750|35771|35765,9.40E-05,,HSA-69481,0.284899036,0
199,3,WikiPathways,,Circadian rhythm genes,0.0032,SKP1|TP53|CREB1,35655,35756|35771|35759,2.20E-04,,WP3594,0.284899036,0
16,2,TISSUES,,Ovary adenocarcinoma cell line,0.0033,TP53|CASP3,35655,35771|35777,5.17E-05,,BTO:0001882,0.283372941,0
16,2,TISSUES,,Cancer stem cell,0.0033,TP53|CTNNB1,35655,35771|35753,5.17E-05,,BTO:0004254,0.283372941,0
8122,12,UniProt Keywords,,Phosphoprotein,0.0033,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,2.43E-05,,KW-0597,0.283372941,0
8,2,COMPARTMENTS,,Survivin complex,0.0035,TP53|CASP3,35655,35771|35777,1.52E-05,,GOCC:1990713,0.280454793,0
4736,10,GO Biological Process,,Negative regulation of cellular process,0.0035,CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,2.62E-05,,GO:0048523,0.280454793,0
655,5,GO Biological Process,,Hemopoiesis,0.0036,TP53|CASP3|HIPK2|CREB1|CTNNB1,35655,35771|35777|35747|35759|35753,2.70E-05,,GO:0030097,0.279057682,0
38,2,WikiPathways,,Parkinsons disease pathway,0.0036,CASP6|CASP3,35655,35762|35777,2.60E-04,,WP2371,0.279057682,0
37,2,WikiPathways,,Amyotrophic lateral sclerosis (ALS),0.0036,TP53|CASP3,35655,35771|35777,2.50E-04,,WP2447,0.279057682,0
37,2,WikiPathways,,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,0.0036,TP53|E2F1,35655,35771|35768,2.50E-04,,WP4320,0.279057682,0
684,5,UniProt Keywords,,Activator,0.0037,TP53|E2F1|TP73|CREB1|CTNNB1,35655,35771|35768|35774|35759|35753,3.32E-05,,KW-0010,0.277698851,0
39,2,WikiPathways,,Bladder cancer,0.0038,TP53|E2F1,35655,35771|35768,2.70E-04,,WP2828,0.276376261,0
2622,8,GO Biological Process,,Regulation of protein metabolic process,0.0039,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|HIPK2|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35747|35753,2.98E-05,,GO:0051246,0.275088028,0
163,3,Reactome Pathways,,Cellular Senescence,0.0039,CDK2|TP53|E2F1,35655,35750|35771|35768,1.20E-04,,HSA-2559583,0.275088028,0
453,4,Reactome Pathways,,Signaling by Interleukins,0.0039,SKP1|TP53|CASP3|CREB1,35655,35756|35771|35777|35759,1.20E-04,,HSA-449147,0.275088028,0
25,2,Reactome Pathways,,Cyclin A/B1/B2 associated events during G2/M transition,0.0039,CDK2|CDK1,35655,35750|35765,1.20E-04,,HSA-69273,0.275088028,0
103,3,GO Biological Process,,Response to hydrogen peroxide,0.0041,CASP3|PRKCD|CDK1,35655,35777|35744|35765,3.21E-05,,GO:0042542,0.272607801,0
27,2,Reactome Pathways,,Pyroptosis,0.0042,TP53|CASP3,35655,35771|35777,1.40E-04,,HSA-5620971,0.271412703,0
328,4,GO Biological Process,,Regulation of protein stability,0.0043,TP53|CASP3|PRKCD|CREB1,35655,35771|35777|35744|35759,3.52E-05,,GO:0031647,0.270245726,0
42,2,WikiPathways,,TNF-related weak inducer of apoptosis (TWEAK) signaling pathway,0.0043,CASP3|CTNNB1,35655,35777|35753,3.20E-04,,WP2036,0.270245726,0
43,2,WikiPathways,,Fas ligand pathway and stress induction of heat shock proteins,0.0044,CASP6|CASP3,35655,35762|35777,3.30E-04,,WP314,0.26910558,0
332,4,GO Biological Process,,Regulation of mitotic cell cycle phase transition,0.0045,CDK2|TP53|E2F1|CDK1,35655,35750|35771|35768|35765,3.68E-05,,GO:1901990,0.267991057,0
28,2,Reactome Pathways,,G1/S-Specific Transcription,0.0045,E2F1|CDK1,35655,35768|35765,1.50E-04,,HSA-69205,0.267991057,0
20,2,TISSUES,,Glioblastoma cell line,0.0047,TP53|CASP3,35655,35771|35777,7.80E-05,,BTO:0001530,0.265834447,0
45,2,WikiPathways,,Aryl hydrocarbon receptor pathway,0.0047,CDK2|E2F1,35655,35750|35768,3.60E-04,,WP2586,0.265834447,0
14,2,GO Biological Process,,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",0.0048,TP53|HIPK2,35655,35771|35747,4.06E-05,,GO:0006978,0.264790321,0
712,5,GO Biological Process,,Cell population proliferation,0.0048,TP53|PRKCD|CDK1|HIPK2|CTNNB1,35655,35771|35744|35765|35747|35753,4.02E-05,,GO:0008283,0.264790321,0
713,5,GO Biological Process,,Negative regulation of cell population proliferation,0.0048,TP53|CASP3|E2F1|TP73|CTNNB1,35655,35771|35777|35768|35774|35753,4.05E-05,,GO:0008285,0.264790321,0
716,5,GO Biological Process,,Regulation of cell cycle process,0.0048,CDK2|TP53|E2F1|CDK1|CTNNB1,35655,35750|35771|35768|35765|35753,4.13E-05,,GO:0010564,0.264790321,0
111,3,GO Biological Process,,Regulation of cell cycle G2/M phase transition,0.0048,CDK2|TP53|CDK1,35655,35750|35771|35765,3.99E-05,,GO:1902749,0.264790321,0
21,2,TISSUES,,Glioma cell line,0.0048,TP53|CASP3,35655,35771|35777,8.54E-05,,BTO:0000711,0.264790321,0
2749,8,GO Biological Process,,Regulation of multicellular organismal process,0.0049,TP53|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35771|35744|35768|35774|35765|35747|35759|35753,4.24E-05,,GO:0051239,0.263767724,0
1250,6,GO Biological Process,,Positive regulation of transcription by RNA polymerase II,0.005,TP53|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35771|35768|35774|35747|35759|35753,4.38E-05,,GO:0045944,0.262765787,0
263,3,KEGG Pathways,,Prion disease,0.005,CASP3|PRKCD|CREB1,35655,35777|35744|35759,4.90E-04,,hsa05020,0.262765787,0
245,3,WikiPathways,,MAPK signaling pathway,0.0051,TP53|CASP3|PRKCD,35655,35771|35777|35744,4.00E-04,,WP382,0.261783691,0
48,2,WikiPathways,,Hepatitis C and hepatocellular carcinoma,0.0052,TP53|CASP3,35655,35771|35777,4.10E-04,,WP3646,0.260820667,0
736,5,GO Biological Process,,Protein phosphorylation,0.0053,CDK2|PRKCD|CDK1|HIPK2|CREB1,35655,35750|35744|35765|35747|35759,4.71E-05,,GO:0006468,0.259875987,0
31,2,Reactome Pathways,,Regulation of MECP2 expression and activity,0.0053,HIPK2|CREB1,35655,35747|35759,1.80E-04,,HSA-9022692,0.259875987,0
7,2,DISEASES,,Colon carcinoma,0.0056,TP53|CTNNB1,35655,35771|35753,1.22E-05,,DOID:1520,0.257145342,0
51,2,WikiPathways,,Copper homeostasis,0.0057,TP53|CASP3,35655,35771|35777,4.60E-04,,WP3286,0.256267545,0
58,2,KEGG Pathways,,Endometrial cancer,0.0058,TP53|CTNNB1,35655,35771|35753,5.90E-04,,hsa05213,0.255405016,0
52,2,WikiPathways,,Netrin-UNC5B signaling pathway,0.0058,TP53|CASP3,35655,35771|35777,4.80E-04,,WP4747,0.255405016,0
33,2,Reactome Pathways,,Oncogene Induced Senescence,0.0059,TP53|E2F1,35655,35771|35768,2.00E-04,,HSA-2559585,0.254557231,0
368,4,GO Biological Process,,Response to oxidative stress,0.0061,TP53|CASP3|PRKCD|CDK1,35655,35771|35777|35744|35765,5.48E-05,,GO:0006979,0.252903938,0
124,3,GO Biological Process,,Regulation of DNA binding,0.0061,E2F1|HIPK2|CTNNB1,35655,35768|35747|35753,5.51E-05,,GO:0051101,0.252903938,0
1850,7,GO Cellular Component,,Chromosome,0.0063,CDK2|TP53|E2F1|TP73|CDK1|CREB1|CTNNB1,35655,35750|35771|35768|35774|35765|35759|35753,3.37E-05,,GO:0005694,0.251303987,0
775,5,GO Biological Process,,Brain development,0.0064,TP53|CASP3|E2F1|CREB1|CTNNB1,35655,35771|35777|35768|35759|35753,6.02E-05,,GO:0007420,0.25052296,0
3910,9,GO Biological Process,,Protein metabolic process,0.0064,SKP1|CASP6|CDK2|CASP3|PRKCD|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35777|35744|35765|35747|35759|35753,5.88E-05,,GO:0019538,0.25052296,0
1322,6,GO Biological Process,,"Negative regulation of transcription, DNA-templated",0.0064,CDK2|TP53|E2F1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35768|35747|35759|35753,6.00E-05,,GO:0045892,0.25052296,0
1332,6,GO Biological Process,,Positive regulation of developmental process,0.0064,E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35768|35774|35765|35747|35759|35753,6.26E-05,,GO:0051094,0.25052296,0
375,4,GO Biological Process,,Regulation of binding,0.0064,PRKCD|E2F1|HIPK2|CTNNB1,35655,35744|35768|35747|35753,5.89E-05,,GO:0051098,0.25052296,0
128,3,GO Biological Process,,Cellular response to hypoxia,0.0064,TP53|E2F1|HIPK2,35655,35771|35768|35747,6.04E-05,,GO:0071456,0.25052296,0
55,2,WikiPathways,,Overlap between signal transduction pathways contributing to LMNA laminopathies,0.0064,E2F1|CTNNB1,35655,35768|35753,5.30E-04,,WP4879,0.25052296,0
64,2,KEGG Pathways,,Mitophagy - animal,0.0065,TP53|E2F1,35655,35771|35768,7.10E-04,,hsa04137,0.249754042,0
295,3,KEGG Pathways,,Huntington disease,0.0065,TP53|CASP3|CREB1,35655,35771|35777|35759,6.80E-04,,hsa05016,0.249754042,0
63,2,KEGG Pathways,,Basal cell carcinoma,0.0065,TP53|CTNNB1,35655,35771|35753,6.90E-04,,hsa05217,0.249754042,0
35,2,Reactome Pathways,,Calmodulin induced events,0.0065,PRKCD|CREB1,35655,35744|35759,2.20E-04,,HSA-111933,0.249754042,0
390,4,UniProt Keywords,,Serine/threonine-protein kinase,0.0066,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,6.85E-05,,KW-0723,0.248996864,0
1702,6,Reactome Pathways,,Disease,0.0068,SKP1|CDK2|TP53|E2F1|CREB1|CTNNB1,35655,35756|35750|35771|35768|35759|35753,2.50E-04,,HSA-1643685,0.24751633,0
1041,5,Reactome Pathways,,Innate Immune System,0.0068,SKP1|TP53|PRKCD|CREB1|CTNNB1,35655,35756|35771|35744|35759|35753,2.40E-04,,HSA-168249,0.24751633,0
391,4,GO Biological Process,,Forebrain development,0.007,CASP3|E2F1|CREB1|CTNNB1,35655,35777|35768|35759|35753,6.92E-05,,GO:0030900,0.246078717,0
68,2,KEGG Pathways,,Non-small cell lung cancer,0.0071,TP53|E2F1,35655,35771|35768,8.00E-04,,hsa05223,0.245375241,0
136,3,GO Biological Process,,Regulation of DNA replication,0.0073,CDK2|TP53|CDK1,35655,35750|35771|35765,7.21E-05,,GO:0006275,0.243997536,0
145,3,UniProt Keywords,,Biological rhythms,0.0073,TP53|CDK1|CREB1,35655,35771|35765|35759,8.68E-05,,KW-0090,0.243997536,0
70,2,KEGG Pathways,,Platinum drug resistance,0.0073,TP53|CASP3,35655,35771|35777,8.50E-04,,hsa01524,0.243997536,0
71,2,KEGG Pathways,,Pancreatic cancer,0.0073,TP53|E2F1,35655,35771|35768,8.70E-04,,hsa05212,0.243997536,0
71,2,KEGG Pathways,,Glioma,0.0073,TP53|E2F1,35655,35771|35768,8.70E-04,,hsa05214,0.243997536,0
72,2,KEGG Pathways,,Melanoma,0.0073,TP53|E2F1,35655,35771|35768,9.00E-04,,hsa05218,0.243997536,0
39,2,Reactome Pathways,,Ovarian tumor domain proteases,0.0074,TP53|CDK1,35655,35771|35765,2.70E-04,,HSA-5689896,0.243322775,0
39,2,Reactome Pathways,,Transcriptional Regulation by VENTX,0.0074,TP53|CTNNB1,35655,35771|35753,2.70E-04,,HSA-8853884,0.243322775,0
7242,12,GO Molecular Function,,Protein binding,0.0076,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35768|35774|35765|35747|35759|35753,6.14E-06,,GO:0005515,0.242000184,0
75,2,KEGG Pathways,,Chronic myeloid leukemia,0.0076,TP53|E2F1,35655,35771|35768,9.70E-04,,hsa05220,0.242000184,0
2101,7,GO Biological Process,,Gene expression,0.0077,CASP6|CDK2|TP53|CASP3|E2F1|CREB1|CTNNB1,35655,35762|35750|35771|35777|35768|35759|35753,7.71E-05,,GO:0010467,0.241351885,0
15,2,GO Cellular Component,,Caspase complex,0.0078,CASP6|CASP3,35655,35762|35777,4.60E-05,,GO:0008303,0.240711951,0
9,2,DISEASES,,Colorectal carcinoma,0.0078,TP53|CTNNB1,35655,35771|35753,1.86E-05,,DOID:0080199,0.240711951,0
3,2,Pfam,,P53 DNA-binding domain,0.0078,TP53|TP73,35655,35771|35774,3.39E-06,,PF00870,0.240711951,0
3,2,Pfam,,P53 tetramerisation motif,0.0078,TP53|TP73,35655,35771|35774,3.39E-06,,PF07710,0.240711951,0
62,2,WikiPathways,,Prader-Willi and Angelman syndrome,0.0079,TP53|E2F1,35655,35771|35768,6.70E-04,,WP3998,0.240080169,0
2121,7,GO Biological Process,,Immune system process,0.008,CASP6|TP53|CASP3|PRKCD|HIPK2|CREB1|CTNNB1,35655,35762|35771|35777|35744|35747|35759|35753,8.20E-05,,GO:0002376,0.239456335,0
63,2,WikiPathways,,Endometrial cancer,0.0081,TP53|CTNNB1,35655,35771|35753,6.90E-04,,WP4155,0.23884025,0
21,2,GO Biological Process,,Lens morphogenesis in camera-type eye,0.0083,HIPK2|CTNNB1,35655,35747|35753,8.54E-05,,GO:0002089,0.237630575,0
835,5,GO Biological Process,,Cell cycle process,0.0083,CDK2|TP53|E2F1|CDK1|CTNNB1,35655,35750|35771|35768|35765|35753,8.56E-05,,GO:0022402,0.237630575,0
349,3,KEGG Pathways,,PI3K-Akt signaling pathway,0.0084,CDK2|TP53|CREB1,35655,35750|35771|35759,0.0011,,hsa04151,0.237036626,0
66,2,WikiPathways,,AGE/RAGE pathway,0.0087,CASP3|PRKCD,35655,35777|35744,7.60E-04,,WP2324,0.2352963,0
150,3,GO Biological Process,,Response to UV,0.0091,TP53|CASP3|PRKCD,35655,35771|35777|35744,9.58E-05,,GO:0009411,0.233066972,0
5436,10,GO Biological Process,,Cellular component organization,0.0091,CASP6|CDK2|TP53|CASP3|PRKCD|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35750|35771|35777|35744|35774|35765|35747|35759|35753,9.55E-05,,GO:0016043,0.233066972,0
68,2,WikiPathways,,RAC1/PAK1/p38/MMP2 pathway,0.0091,TP53|CTNNB1,35655,35771|35753,8.00E-04,,WP3303,0.233066972,0
3085,8,GO Biological Process,,Regulation of molecular function,0.0094,SKP1|CASP6|TP53|CASP3|PRKCD|E2F1|HIPK2|CTNNB1,35655,35756|35762|35771|35777|35744|35768|35747|35753,9.93E-05,,GO:0065009,0.231458371,0
87,2,KEGG Pathways,,Longevity regulating pathway,0.0096,TP53|CREB1,35655,35771|35759,0.0013,,hsa04211,0.230414244,0
2203,7,GO Biological Process,,Nucleic acid metabolic process,0.0097,CDK2|TP53|E2F1|TP73|CDK1|CREB1|CTNNB1,35655,35750|35771|35768|35774|35765|35759|35753,1.00E-04,,GO:0090304,0.22990031,0
72,2,WikiPathways,,MECP2 and associated Rett syndrome,0.01,E2F1|CREB1,35655,35768|35759,9.00E-04,,WP3584,0.22838971,0
12,2,DISEASES,,Nephroblastoma,0.0101,TP53|CTNNB1,35655,35771|35753,3.08E-05,,DOID:2154,0.227896231,0
17,2,COMPARTMENTS,,BAX complex,0.0102,TP53|CASP3,35655,35771|35777,5.78E-05,,GOCC:0097144,0.227407615,0
17,2,COMPARTMENTS,,Enzyme activator complex,0.0102,TP53|CASP3,35655,35771|35777,5.78E-05,,GOCC:0150005,0.227407615,0
1019,5,TISSUES,,Hematopoietic cell,0.0106,SKP1|CASP6|CASP3|TP73|CDK1,35655,35756|35762|35777|35774|35765,2.20E-04,,BTO:0000574,0.22549991,0
532,4,TISSUES,,Mouth,0.0106,SKP1|TP53|CASP3|CTNNB1,35655,35756|35771|35777|35753,2.20E-04,,BTO:0001090,0.22549991,0
25,2,GO Biological Process,,Lung epithelial cell differentiation,0.0108,CREB1|CTNNB1,35655,35759|35753,1.20E-04,,GO:0060487,0.224572889,0
25,2,GO Biological Process,,Positive regulation of muscle tissue development,0.0108,CREB1|CTNNB1,35655,35759|35753,1.20E-04,,GO:1901863,0.224572889,0
19,2,COMPARTMENTS,,Caspase complex,0.0109,CASP6|CASP3,35655,35762|35777,7.09E-05,,GOCC:0008303,0.224115796,0
336,3,WikiPathways,,PI3K-Akt signaling pathway,0.0109,CDK2|TP53|CREB1,35655,35750|35771|35759,9.90E-04,,WP4172,0.224115796,0
94,2,KEGG Pathways,,Endocrine resistance,0.011,TP53|E2F1,35655,35771|35768,0.0015,,hsa01522,0.223662878,0
95,2,KEGG Pathways,,Progesterone-mediated oocyte maturation,0.011,CDK2|CDK1,35655,35750|35765,0.0015,,hsa04914,0.223662878,0
95,2,KEGG Pathways,,Melanogenesis,0.011,CREB1|CTNNB1,35655,35759|35753,0.0015,,hsa04916,0.223662878,0
96,2,KEGG Pathways,,AGE-RAGE signaling pathway in diabetic complications,0.011,CASP3|PRKCD,35655,35777|35744,0.0016,,hsa04933,0.223662878,0
1505,6,GO Biological Process,,Positive regulation of multicellular organismal process,0.0111,E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35768|35774|35765|35747|35759|35753,1.20E-04,,GO:0051240,0.223214059,0
164,3,GO Biological Process,,Regulation of G1/S transition of mitotic cell cycle,0.0111,CDK2|TP53|E2F1,35655,35750|35771|35768,1.20E-04,,GO:2000045,0.223214059,0
912,5,GO Biological Process,,Regulation of transferase activity,0.0115,SKP1|TP53|CASP3|PRKCD|CTNNB1,35655,35756|35771|35777|35744|35753,1.30E-04,,GO:0051338,0.221458329,0
167,3,GO Biological Process,,Negative regulation of mitotic cell cycle phase transition,0.0115,CDK2|TP53|CDK1,35655,35750|35771|35765,1.30E-04,,GO:1901991,0.221458329,0
177,3,UniProt Keywords,,Tumor suppressor,0.0116,TP53|PRKCD|TP73,35655,35771|35744|35774,1.60E-04,,KW-0043,0.221028939,0
259,4,SMART Domains,,"Serine/Threonine protein kinases, catalytic domain",0.0116,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,1.41E-05,,SM00220,0.221028939,0
27,2,GO Biological Process,,Developmental induction,0.0118,HIPK2|CTNNB1,35655,35747|35753,1.40E-04,,GO:0031128,0.220181155,0
173,3,GO Biological Process,,Mitotic cell cycle phase transition,0.0122,CDK2|E2F1|CDK1,35655,35750|35768|35765,1.50E-04,,GO:0044772,0.218527862,0
3246,8,GO Biological Process,,Animal organ development,0.0122,TP53|CASP3|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35771|35777|35768|35774|35765|35747|35759|35753,1.40E-04,,GO:0048513,0.218527862,0
2399,7,UniProt Keywords,,Ubl conjugation,0.0122,SKP1|TP53|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35771|35774|35765|35747|35759|35753,1.80E-04,,KW-0832,0.218527862,0
1560,6,GO Biological Process,,Regulation of protein modification process,0.0126,SKP1|TP53|CASP3|PRKCD|HIPK2|CTNNB1,35655,35756|35771|35777|35744|35747|35753,1.50E-04,,GO:0031399,0.21692791,0
12,2,SMART Domains,,"Caspase, interleukin-1 beta converting enzyme (ICE) homologues",0.0126,CASP6|CASP3,35655,35762|35777,3.08E-05,,SM00115,0.21692791,0
945,5,GO Biological Process,,Positive regulation of cell population proliferation,0.0127,CDK2|E2F1|CDK1|HIPK2|CTNNB1,35655,35750|35768|35765|35747|35753,1.50E-04,,GO:0008284,0.216535859,0
106,2,KEGG Pathways,,Insulin resistance,0.0127,PRKCD|CREB1,35655,35744|35759,0.0019,,hsa04931,0.216535859,0
3054,8,COMPARTMENTS,,Cytosol,0.0133,SKP1|CASP6|CDK2|TP53|CASP3|PRKCD|CDK1|CTNNB1,35655,35756|35762|35750|35771|35777|35744|35765|35753,9.22E-05,,GOCC:0005829,0.21424649,0
1582,6,GO Biological Process,,Regulation of cell differentiation,0.0134,TP53|E2F1|TP73|CDK1|CREB1|CTNNB1,35655,35771|35768|35774|35765|35759|35753,1.60E-04,,GO:0045595,0.213874996,0
111,2,KEGG Pathways,,TNF signaling pathway,0.0136,CASP3|CREB1,35655,35777|35759,0.0021,,hsa04668,0.213140254,0
971,5,GO Biological Process,,Negative regulation of transcription by RNA polymerase II,0.014,CDK2|TP53|E2F1|HIPK2|CTNNB1,35655,35750|35771|35768|35747|35753,1.70E-04,,GO:0000122,0.21170264,0
497,4,GO Biological Process,,DNA repair,0.014,CDK2|TP53|TP73|CDK1,35655,35750|35771|35774|35765,1.70E-04,,GO:0006281,0.21170264,0
1979,6,Reactome Pathways,,Immune System,0.014,SKP1|TP53|CASP3|PRKCD|CREB1|CTNNB1,35655,35756|35771|35777|35744|35759|35753,5.60E-04,,HSA-168256,0.21170264,0
31,2,GO Biological Process,,Response to X-ray,0.0141,TP53|CASP3,35655,35771|35777,1.80E-04,,GO:0010165,0.211349655,0
10,2,STRING Clusters,,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.0146,CDK2|E2F1,35655,35750|35768,2.23E-05,,CL:6926,0.209621459,0
10,2,STRING Clusters,,"Mixed, incl. P53 DNA-binding domain, and SWIB/MDM2 domain",0.0146,TP53|TP73,35655,35771|35774,2.23E-05,,CL:6997,0.209621459,0
32,2,GO Biological Process,,Mitotic G1 DNA damage checkpoint signaling,0.0147,CDK2|TP53,35655,35750|35771,1.90E-04,,GO:0031571,0.209282931,0
59,2,Reactome Pathways,,SCF(Skp2)-mediated degradation of p27/p21,0.015,SKP1|CDK2,35655,35756|35750,6.10E-04,,HSA-187577,0.208280994,0
90,2,WikiPathways,,Androgen receptor signaling pathway,0.015,CREB1|CTNNB1,35655,35759|35753,0.0014,,WP138,0.208280994,0
90,2,WikiPathways,,T-cell receptor signaling pathway,0.015,PRKCD|CREB1,35655,35744|35759,0.0014,,WP69,0.208280994,0
60,2,Reactome Pathways,,DNA Damage/Telomere Stress Induced Senescence,0.0151,CDK2|TP53,35655,35750|35771,6.30E-04,,HSA-2559586,0.207951463,0
92,2,WikiPathways,,TNF-alpha signaling pathway,0.0152,SKP1|CASP3,35655,35756|35777,0.0014,,WP231,0.207624108,0
33,2,GO Biological Process,,Histone phosphorylation,0.0153,CDK2|CDK1,35655,35750|35765,2.00E-04,,GO:0016572,0.207298899,0
93,2,WikiPathways,,Thyroid hormones production and peripheral downstream signaling effects,0.0153,TP53|CTNNB1,35655,35771|35753,0.0015,,WP4746,0.207298899,0
61,2,Reactome Pathways,,MAP kinase activation,0.0155,SKP1|CREB1,35655,35756|35759,6.50E-04,,HSA-450294,0.206654809,0
120,2,KEGG Pathways,,Thyroid hormone signaling pathway,0.0156,TP53|CTNNB1,35655,35771|35753,0.0024,,hsa04919,0.206335874,0
5506,10,GO Cellular Component,,Protein-containing complex,0.0157,SKP1|CASP6|CDK2|TP53|CASP3|E2F1|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35762|35750|35771|35777|35768|35765|35747|35759|35753,1.10E-04,,GO:0032991,0.206018978,0
1717,6,UniProt Keywords,,Isopeptide bond,0.0157,SKP1|TP53|TP73|CDK1|HIPK2|CREB1,35655,35756|35771|35774|35765|35747|35759,2.60E-04,,KW-1017,0.206018978,0
62,2,Reactome Pathways,,Pre-NOTCH Transcription and Translation,0.0158,TP53|E2F1,35655,35771|35768,6.70E-04,,HSA-1912408,0.205704093,0
34,2,GO Biological Process,,Fibroblast proliferation,0.016,TP53|CDK1,35655,35771|35765,2.10E-04,,GO:0048144,0.205080258,0
1018,5,GO Biological Process,,Positive regulation of protein modification process,0.0164,SKP1|TP53|PRKCD|HIPK2|CTNNB1,35655,35756|35771|35744|35747|35753,2.20E-04,,GO:0031401,0.203855648,0
97,2,WikiPathways,,B cell receptor signaling pathway,0.0164,PRKCD|CREB1,35655,35744|35759,0.0016,,WP23,0.203855648,0
757,5,DISEASES,,Organ system cancer,0.0165,CDK2|TP53|CASP3|E2F1|CTNNB1,35655,35750|35771|35777|35768|35753,5.38E-05,,DOID:0050686,0.203554162,0
98,2,WikiPathways,,Hippo signaling regulation pathways,0.0165,PRKCD|CTNNB1,35655,35744|35753,0.0016,,WP4540,0.203554162,0
17,2,DISEASES,,Hepatocellular carcinoma,0.0166,TP53|CTNNB1,35655,35771|35753,5.78E-05,,DOID:684,0.203254499,0
64,2,Reactome Pathways,,p53-Dependent G1 DNA Damage Response,0.0166,CDK2|TP53,35655,35750|35771,7.10E-04,,HSA-69563,0.203254499,0
35,2,GO Biological Process,,Regulation of glial cell proliferation,0.0168,TP53|E2F1,35655,35771|35768,2.20E-04,,GO:0060251,0.202660549,0
100,2,WikiPathways,,Burn wound healing,0.0169,TP53|CASP3,35655,35771|35777,0.0017,,WP5055,0.202366221,0
244,3,TISSUES,,Erythroleukemia cell,0.017,CASP3|CDK1|CREB1,35655,35777|35765|35759,3.90E-04,,BTO:0000426,0.202073629,0
537,4,GO Biological Process,,Mitotic cell cycle process,0.0173,CDK2|TP53|E2F1|CDK1,35655,35750|35771|35768|35765,2.30E-04,,GO:1903047,0.20120607,0
306,3,Reactome Pathways,,Intracellular signaling by second messengers,0.0173,TP53|PRKCD|CREB1,35655,35771|35744|35759,7.60E-04,,HSA-9006925,0.20120607,0
1693,6,GO Biological Process,,Positive regulation of cell communication,0.0175,TP53|PRKCD|TP73|HIPK2|CREB1|CTNNB1,35655,35771|35744|35774|35747|35759|35753,2.40E-04,,GO:0010647,0.200636015,0
1038,5,GO Biological Process,,Negative regulation of protein metabolic process,0.0175,TP53|CASP3|PRKCD|HIPK2|CTNNB1,35655,35771|35777|35744|35747|35753,2.40E-04,,GO:0051248,0.200636015,0
1698,6,GO Biological Process,,Positive regulation of signaling,0.0176,TP53|PRKCD|TP73|HIPK2|CREB1|CTNNB1,35655,35771|35744|35774|35747|35759|35753,2.40E-04,,GO:0023056,0.200353426,0
129,2,KEGG Pathways,,Fluid shear stress and atherosclerosis,0.0176,TP53|CTNNB1,35655,35771|35753,0.0028,,hsa05418,0.200353426,0
476,4,COMPARTMENTS,,Chromatin,0.0178,TP53|E2F1|CREB1|CTNNB1,35655,35771|35768|35759|35753,1.50E-04,,GOCC:0000785,0.199793034,0
68,2,Reactome Pathways,,Circadian Clock,0.0179,SKP1|CREB1,35655,35756|35759,8.00E-04,,HSA-400253,0.199515195,0
548,4,GO Biological Process,,Heart development,0.0181,TP53|CASP3|CDK1|CTNNB1,35655,35771|35777|35765|35753,2.50E-04,,GO:0007507,0.198964142,0
951,5,COMPARTMENTS,,Chromosome,0.0182,TP53|E2F1|CDK1|CREB1|CTNNB1,35655,35771|35768|35765|35759|35753,1.60E-04,,GOCC:0005694,0.198690896,0
1575,6,COMPARTMENTS,,Cytoskeleton,0.0182,CDK2|TP53|CASP3|E2F1|CDK1|CTNNB1,35655,35750|35771|35777|35768|35765|35753,1.60E-04,,GOCC:0005856,0.198690896,0
3309,8,COMPARTMENTS,,Intracellular non-membrane-bounded organelle,0.0182,CASP6|CDK2|TP53|CASP3|E2F1|CDK1|CREB1|CTNNB1,35655,35762|35750|35771|35777|35768|35765|35759|35753,1.70E-04,,GOCC:0043232,0.198690896,0
133,2,KEGG Pathways,,Estrogen signaling pathway,0.0183,PRKCD|CREB1,35655,35744|35759,0.0029,,hsa04915,0.198419146,0
9,2,GO Molecular Function,,Cysteine-type endopeptidase activity involved in execution phase of apoptosis,0.0184,CASP6|CASP3,35655,35762|35777,1.86E-05,,GO:0097200,0.198148877,0
70,2,Reactome Pathways,,Orc1 removal from chromatin,0.0186,SKP1|CDK2,35655,35756|35750,8.50E-04,,HSA-68949,0.197612718,0
215,3,GO Biological Process,,Protein stabilization,0.0194,TP53|PRKCD|CREB1,35655,35771|35744|35759,2.70E-04,,GO:0050821,0.195524233,0
216,3,GO Biological Process,,Anterior/posterior pattern specification,0.0195,TP53|HIPK2|CTNNB1,35655,35771|35747|35753,2.80E-04,,GO:0009952,0.19526925,0
39,2,GO Biological Process,,Regulation of cardiac muscle cell proliferation,0.0195,TP73|CDK1,35655,35774|35765,2.70E-04,,GO:0060043,0.19526925,0
39,2,GO Biological Process,,Regulation of neuroblast proliferation,0.0195,TP53|CTNNB1,35655,35771|35753,2.70E-04,,GO:1902692,0.19526925,0
428,3,WikiPathways,,VEGFA-VEGFR2 signaling,0.0195,PRKCD|CREB1|CTNNB1,35655,35744|35759|35753,0.002,,WP3888,0.19526925,0
40,2,GO Biological Process,,Positive regulation of DNA replication,0.0202,CDK2|CDK1,35655,35750|35765,2.90E-04,,GO:0045740,0.193520155,0
2586,7,GO Biological Process,,Regulation of transcription by RNA polymerase II,0.0204,CDK2|TP53|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35750|35771|35768|35774|35747|35759|35753,2.90E-04,,GO:0006357,0.193031538,0
41,2,GO Biological Process,,Negative regulation of gliogenesis,0.0209,TP53|CTNNB1,35655,35771|35753,3.00E-04,,GO:0014014,0.191830651,0
224,3,GO Biological Process,,Cellular response to oxidative stress,0.021,TP53|PRKCD|CDK1,35655,35771|35744|35765,3.10E-04,,GO:0034599,0.191593924,0
42,2,GO Biological Process,,Positive regulation of protein import into nucleus,0.0216,PRKCD|CDK1,35655,35744|35765,3.20E-04,,GO:0042307,0.190196812,0
227,3,GO Biological Process,,Positive regulation of neurogenesis,0.0217,E2F1|TP73|CTNNB1,35655,35768|35774|35753,3.20E-04,,GO:0050769,0.189967739,0
77,2,Reactome Pathways,,G2/M DNA damage checkpoint,0.0222,TP53|CDK1,35655,35771|35765,0.001,,HSA-69473,0.188837982,0
77,2,Reactome Pathways,,The role of GTSE1 in G2/M progression after G2 checkpoint,0.0222,TP53|CDK1,35655,35771|35765,0.001,,HSA-8852276,0.188837982,0
1710,6,COMPARTMENTS,,Catalytic complex,0.0223,SKP1|CASP6|CDK2|TP53|CASP3|CDK1,35655,35756|35762|35750|35771|35777|35765,2.50E-04,,GOCC:1902494,0.188615087,0
117,2,WikiPathways,,Osteoblast differentiation and related diseases,0.0224,PRKCD|CTNNB1,35655,35744|35753,0.0023,,WP4787,0.188393188,0
590,4,GO Biological Process,,Embryonic morphogenesis,0.0225,TP53|CASP3|HIPK2|CTNNB1,35655,35771|35777|35747|35753,3.30E-04,,GO:0048598,0.188172278,0
3654,8,GO Biological Process,,Regulation of biological quality,0.0229,CASP6|TP53|CASP3|PRKCD|E2F1|HIPK2|CREB1|CTNNB1,35655,35762|35771|35777|35744|35768|35747|35759|35753,3.40E-04,,GO:0065008,0.187298349,0
44,2,GO Biological Process,,Regulation of oligodendrocyte differentiation,0.0231,TP73|CTNNB1,35655,35774|35753,3.50E-04,,GO:0048713,0.186867093,0
598,4,GO Biological Process,,Behavior,0.0232,TP53|CASP3|HIPK2|CREB1,35655,35771|35777|35747|35759,3.50E-04,,GO:0007610,0.186652863,0
1131,5,GO Biological Process,,Generation of neurons,0.0234,TP53|CASP3|HIPK2|CREB1|CTNNB1,35655,35771|35777|35747|35759|35753,3.50E-04,,GO:0048699,0.186227159,0
2674,7,GO Biological Process,,Protein modification process,0.0237,SKP1|CDK2|PRKCD|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35750|35744|35765|35747|35759|35753,3.60E-04,,GO:0036211,0.185595377,0
45,2,GO Biological Process,,Leukocyte apoptotic process,0.0237,TP53|CASP3,35655,35771|35777,3.60E-04,,GO:0071887,0.185595377,0
154,2,KEGG Pathways,,Hippo signaling pathway,0.0238,TP73|CTNNB1,35655,35774|35753,0.0039,,hsa04390,0.185386559,0
3,2,InterPro Domains,,p53 tumour suppressor family,0.0244,TP53|TP73,35655,35771|35774,3.39E-06,,IPR002117,0.184151785,0
3,2,InterPro Domains,,"p53, tetramerisation domain",0.0244,TP53|TP73,35655,35771|35774,3.39E-06,,IPR010991,0.184151785,0
3,2,InterPro Domains,,"p53, DNA-binding domain",0.0244,TP53|TP73,35655,35771|35774,3.39E-06,,IPR011615,0.184151785,0
6,2,InterPro Domains,,"p53/RUNT-type transcription factor, DNA-binding domain superfamily",0.0244,TP53|TP73,35655,35771|35774,9.49E-06,,IPR012346,0.184151785,0
5,2,InterPro Domains,,p53-like tetramerisation domain superfamily,0.0244,TP53|TP73,35655,35771|35774,7.12E-06,,IPR036674,0.184151785,0
82,2,Reactome Pathways,,Degradation of beta-catenin by the destruction complex,0.0244,SKP1|CTNNB1,35655,35756|35753,0.0012,,HSA-195253,0.184151785,0
4899,9,GO Biological Process,,Regulation of gene expression,0.0246,CDK2|TP53|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35744|35768|35774|35765|35747|35759|35753,3.80E-04,,GO:0010468,0.183746932,0
243,3,GO Biological Process,,Negative regulation of cellular catabolic process,0.0252,TP53|E2F1|HIPK2,35655,35771|35768|35747,3.90E-04,,GO:0031330,0.182551833,0
12,2,GO Molecular Function,,MDM2/MDM4 family protein binding,0.0253,TP53|TP73,35655,35771|35774,3.08E-05,,GO:0097371,0.18235542,0
698,4,TISSUES,,Lymphocyte,0.0263,CASP6|CASP3|TP73|CDK1,35655,35762|35777|35774|35765,6.30E-04,,BTO:0000775,0.180432924,0
702,5,GO Molecular Function,,Protein kinase binding,0.0265,TP53|PRKCD|E2F1|TP73|CTNNB1,35655,35771|35744|35768|35774|35753,3.76E-05,,GO:0019901,0.180057209,0
3759,8,GO Biological Process,,Regulation of RNA metabolic process,0.0267,CDK2|TP53|PRKCD|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35750|35771|35744|35768|35774|35747|35759|35753,4.20E-04,,GO:0051252,0.179684318,0
165,2,KEGG Pathways,,Tuberculosis,0.0267,CASP3|CREB1,35655,35777|35759,0.0045,,hsa05152,0.179684318,0
5095,9,UniProt Keywords,,Cytoplasm,0.0268,CASP6|CDK2|TP53|CASP3|PRKCD|TP73|CDK1|HIPK2|CTNNB1,35655,35762|35750|35771|35777|35744|35774|35765|35747|35753,5.20E-04,,KW-0963,0.179498919,0
10,2,InterPro Domains,,"Peptidase family C14A, His active site",0.0268,CASP6|CASP3,35655,35762|35777,2.23E-05,,IPR016129,0.179498919,0
250,3,GO Biological Process,,Cell fate commitment,0.0269,TP53|CASP3|CTNNB1,35655,35771|35777|35753,4.20E-04,,GO:0045165,0.179314211,0
49,2,GO Biological Process,,Response to antibiotic,0.0271,TP53|CASP3,35655,35771|35777,4.30E-04,,GO:0046677,0.178946845,0
13,2,InterPro Domains,,"Peptidase C14, p20 domain",0.0271,CASP6|CASP3,35655,35762|35777,3.55E-05,,IPR001309,0.178946845,0
11,2,InterPro Domains,,"Peptidase C14, caspase non-catalytic subunit p10",0.0271,CASP6|CASP3,35655,35762|35777,2.64E-05,,IPR002138,0.178946845,0
11,2,InterPro Domains,,Peptidase C14 family,0.0271,CASP6|CASP3,35655,35762|35777,2.64E-05,,IPR002398,0.178946845,0
310,4,InterPro Domains,,"Serine/threonine-protein kinase, active site",0.0271,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,2.83E-05,,IPR008271,0.178946845,0
13,2,InterPro Domains,,"Peptidase C14, caspase domain",0.0271,CASP6|CASP3,35655,35762|35777,3.55E-05,,IPR011600,0.178946845,0
12,2,InterPro Domains,,"Peptidase C14A, caspase catalytic domain",0.0271,CASP6|CASP3,35655,35762|35777,3.08E-05,,IPR015917,0.178946845,0
13,2,InterPro Domains,,Caspase-like domain superfamily,0.0271,CASP6|CASP3,35655,35762|35777,3.55E-05,,IPR029030,0.178946845,0
11,2,InterPro Domains,,"Peptidase family C14A, cysteine active site",0.0271,CASP6|CASP3,35655,35762|35777,2.64E-05,,IPR033139,0.178946845,0
87,2,Reactome Pathways,,Regulation of PLK1 Activity at G2/M Transition,0.0271,SKP1|CDK1,35655,35756|35765,0.0013,,HSA-2565942,0.178946845,0
252,3,GO Biological Process,,Response to alcohol,0.0272,CDK1|CREB1|CTNNB1,35655,35765|35759|35753,4.30E-04,,GO:0097305,0.178764177,0
50,2,GO Biological Process,,Neuroblast proliferation,0.0277,TP53|CTNNB1,35655,35771|35753,4.40E-04,,GO:0007405,0.177860797,0
50,2,GO Biological Process,,mRNA transcription,0.0277,TP53|CREB1,35655,35771|35759,4.40E-04,,GO:0009299,0.177860797,0
1190,5,GO Biological Process,,Regulation of organelle organization,0.0277,CASP6|CDK2|TP53|PRKCD|CTNNB1,35655,35762|35750|35771|35744|35753,4.50E-04,,GO:0033043,0.177860797,0
361,4,GO Molecular Function,,Protein serine kinase activity,0.0279,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,5.09E-05,,GO:0106310,0.177504003,0
641,4,GO Biological Process,,Enzyme-linked receptor protein signaling pathway,0.028,TP53|CASP3|HIPK2|CTNNB1,35655,35771|35777|35747|35753,4.60E-04,,GO:0007167,0.177326563,0
51,2,GO Biological Process,,Regulation of telomerase activity,0.0282,TP53|CTNNB1,35655,35771|35753,4.60E-04,,GO:0051972,0.176973578,0
43,2,COMPARTMENTS,,Euchromatin,0.0283,CREB1|CTNNB1,35655,35759|35753,3.30E-04,,GOCC:0000791,0.176798023,0
92,2,Reactome Pathways,,Oxidative Stress Induced Senescence,0.0293,TP53|E2F1,35655,35771|35768,0.0014,,HSA-2559580,0.17507583,0
382,4,InterPro Domains,,"Protein kinase, ATP binding site",0.0303,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,6.33E-05,,IPR017441,0.173411439,0
94,2,Reactome Pathways,,Transcriptional regulation by RUNX3,0.0303,TP53|CTNNB1,35655,35771|35753,0.0015,,HSA-8878159,0.173411439,0
54,2,GO Biological Process,,Osteoclast differentiation,0.0312,CREB1|CTNNB1,35655,35759|35753,5.10E-04,,GO:0030316,0.171959798,0
3867,8,GO Biological Process,,System development,0.0312,TP53|CASP3|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35771|35777|35768|35774|35765|35747|35759|35753,5.10E-04,,GO:0048731,0.171959798,0
96,2,Reactome Pathways,,VEGFA-VEGFR2 Pathway,0.0313,PRKCD|CTNNB1,35655,35744|35753,0.0016,,HSA-4420097,0.171801096,0
96,2,Reactome Pathways,,CLEC7A (Dectin-1) signaling,0.0313,SKP1|PRKCD,35655,35756|35744,0.0016,,HSA-5607764,0.171801096,0
47,3,Monarch Phenotype,,Hepatocellular carcinoma,0.0315,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,3.32E-06,,HP:0001402,0.171485209,0
9,2,Monarch Phenotype,,Subacute progressive viral hepatitis,0.0315,TP53|CTNNB1,35655,35771|35753,1.86E-05,,HP:0006572,0.171485209,0
275,4,Monarch Phenotype,,Neoplasm by histology,0.0315,TP53|PRKCD|CREB1|CTNNB1,35655,35771|35744|35759|35753,1.78E-05,,HP:0011792,0.171485209,0
74,3,Monarch Phenotype,,Hepatitis,0.0315,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,1.23E-05,,HP:0012115,0.171485209,0
67,3,Monarch Phenotype,,Fibrous tissue neoplasm,0.0315,PRKCD|CREB1|CTNNB1,35655,35744|35759|35753,9.22E-06,,HP:0012316,0.171485209,0
104,3,Monarch Phenotype,,Soft tissue sarcoma,0.0315,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,3.30E-05,,HP:0030448,0.171485209,0
64,3,Monarch Phenotype,,Neoplasm of the breast,0.0315,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,8.08E-06,,HP:0100013,0.171485209,0
43,3,Monarch Phenotype,,Neoplasm of the lung,0.0315,TP53|TP73|CTNNB1,35655,35771|35774|35753,2.58E-06,,HP:0100526,0.171485209,0
9,2,Monarch Phenotype,,Hemobilia,0.0315,TP53|CTNNB1,35655,35771|35753,1.86E-05,,HP:0100762,0.171485209,0
11,2,Monarch Phenotype,,Epigastric pain,0.0315,TP53|CTNNB1,35655,35771|35753,2.64E-05,,HP:0410019,0.171485209,0
269,3,GO Biological Process,,Muscle cell differentiation,0.0316,CASP3|CDK1|CTNNB1,35655,35777|35765|35753,5.20E-04,,GO:0042692,0.171328016,0
5378,9,TISSUES,,Viscus,0.0319,SKP1|TP53|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35771|35744|35768|35774|35765|35747|35759|35753,8.00E-04,,BTO:0001491,0.170859406,0
668,4,GO Biological Process,,Regulation of MAPK cascade,0.0321,PRKCD|TP73|HIPK2|CTNNB1,35655,35744|35774|35747|35753,5.30E-04,,GO:0043408,0.170549441,0
5117,9,GO Biological Process,,Anatomical structure development,0.0323,CASP6|TP53|CASP3|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35762|35771|35777|35768|35774|35765|35747|35759|35753,5.40E-04,,GO:0048856,0.170241402,0
671,4,GO Biological Process,,Regulation of growth,0.0324,TP53|TP73|CDK1|CREB1,35655,35771|35774|35765|35759,5.40E-04,,GO:0040008,0.170088097,0
48,2,COMPARTMENTS,,Cyclin-dependent protein kinase holoenzyme complex,0.0325,CDK2|CDK1,35655,35750|35765,4.10E-04,,GOCC:0000307,0.169935264,0
6568,10,GO Biological Process,,Cellular metabolic process,0.0327,SKP1|CDK2|TP53|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35756|35750|35771|35744|35768|35774|35765|35747|35759|35753,5.50E-04,,GO:0044237,0.169631004,0
274,3,GO Biological Process,,Negative regulation of transferase activity,0.0327,TP53|CASP3|PRKCD,35655,35771|35777|35744,5.50E-04,,GO:0051348,0.169631004,0
29,2,DISEASES,,Pancreatic cancer,0.0327,TP53|CTNNB1,35655,35771|35753,1.60E-04,,DOID:1793,0.169631004,0
1247,5,GO Biological Process,,Proteolysis,0.0328,SKP1|CASP6|CASP3|CDK1|CTNNB1,35655,35756|35762|35777|35765|35753,5.60E-04,,GO:0006508,0.169479571,0
2084,7,GO Molecular Function,,Enzyme binding,0.0328,TP53|CASP3|PRKCD|E2F1|TP73|CREB1|CTNNB1,35655,35771|35777|35744|35768|35774|35759|35753,7.31E-05,,GO:0019899,0.169479571,0
5278,9,UniProt Keywords,,Nucleus,0.0331,CDK2|TP53|PRKCD|E2F1|TP73|CDK1|HIPK2|CREB1|CTNNB1,35655,35750|35771|35744|35768|35774|35765|35747|35759|35753,6.90E-04,,KW-0539,0.169028028,0
685,4,GO Biological Process,,Negative regulation of cell differentiation,0.0343,TP53|E2F1|TP73|CTNNB1,35655,35771|35768|35774|35753,5.90E-04,,GO:0045596,0.167261876,0
58,2,GO Biological Process,,G2/M transition of mitotic cell cycle,0.0344,CDK2|CDK1,35655,35750|35765,5.90E-04,,GO:0000086,0.167117496,0
58,2,GO Biological Process,,Positive regulation of DNA binding,0.0344,HIPK2|CTNNB1,35655,35747|35753,5.90E-04,,GO:0043388,0.167117496,0
14,2,Monarch Phenotype,,Budd-Chiari syndrome,0.0354,TP53|CTNNB1,35655,35771|35753,4.06E-05,,HP:0002639,0.165696362,0
14,2,Monarch Phenotype,,Anasarca,0.0354,TP53|CTNNB1,35655,35771|35753,4.06E-05,,HP:0012050,0.165696362,0
114,3,Monarch Phenotype,,Neoplasm of the endocrine system,0.0354,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,4.31E-05,,HP:0100568,0.165696362,0
31,2,DISEASES,,Stomach cancer,0.0355,TP53|CTNNB1,35655,35771|35753,1.80E-04,,DOID:10534,0.165556463,0
150,2,WikiPathways,,Hepatitis B infection,0.0357,CASP3|CREB1,35655,35777|35759,0.0037,,WP4666,0.165277843,0
3980,8,GO Biological Process,,Regulation of macromolecule biosynthetic process,0.0361,CDK2|TP53|PRKCD|E2F1|TP73|HIPK2|CREB1|CTNNB1,35655,35750|35771|35744|35768|35774|35747|35759|35753,6.30E-04,,GO:0010556,0.164725256,0
60,2,GO Biological Process,,Positive regulation of epithelial cell differentiation,0.0361,TP73|CTNNB1,35655,35774|35753,6.30E-04,,GO:0030858,0.164725256,0
105,2,Reactome Pathways,,KEAP1-NFE2L2 pathway,0.0366,SKP1|PRKCD,35655,35756|35744,0.0019,,HSA-9755511,0.164043069,0
75,2,TISSUES,,Pharynx,0.0379,SKP1|TP53,35655,35756|35771,9.70E-04,,BTO:0001049,0.162312089,0
17,2,Monarch Phenotype,,Hepatic encephalopathy,0.0379,TP53|CTNNB1,35655,35771|35753,5.78E-05,,HP:0002480,0.162312089,0
763,5,Monarch Phenotype,,Neoplasm,0.0379,TP53|PRKCD|TP73|CREB1|CTNNB1,35655,35771|35744|35774|35759|35753,5.59E-05,,HP:0002664,0.162312089,0
712,4,GO Biological Process,,Regulation of cellular response to stress,0.038,TP53|PRKCD|HIPK2|CTNNB1,35655,35771|35744|35747|35753,6.80E-04,,GO:0080135,0.162181406,0
156,2,WikiPathways,,Myometrial relaxation and contraction pathways,0.0381,PRKCD|CREB1,35655,35744|35759,0.004,,WP289,0.162051067,0
63,2,GO Biological Process,,T cell differentiation in thymus,0.0387,TP53|CTNNB1,35655,35771|35753,6.90E-04,,GO:0033077,0.161276142,0
63,2,GO Biological Process,,Regulation of mitochondrial membrane permeability,0.0387,CASP6|TP53,35655,35762|35771,6.90E-04,,GO:0046902,0.161276142,0
430,3,Reactome Pathways,,Diseases of signal transduction by growth factor receptors and second messengers,0.0387,SKP1|CREB1|CTNNB1,35655,35756|35759|35753,0.002,,HSA-5663202,0.161276142,0
34,2,DISEASES,,B-cell lymphoma,0.0389,TP53|CASP3,35655,35771|35777,2.10E-04,,DOID:707,0.161020501,0
18,2,Monarch Phenotype,,Medulloblastoma,0.0391,TP53|CTNNB1,35655,35771|35753,6.42E-05,,HP:0002885,0.160766171,0
18,2,Monarch Phenotype,,Liver abscess,0.0391,TP53|CTNNB1,35655,35771|35753,6.42E-05,,HP:0100523,0.160766171,0
19,2,Monarch Phenotype,,Hepatic necrosis,0.0393,TP53|CTNNB1,35655,35771|35753,7.09E-05,,HP:0002605,0.160513139,0
160,2,WikiPathways,,Epithelial to mesenchymal transition in colorectal cancer,0.0395,TP53|CTNNB1,35655,35771|35753,0.0042,,WP4239,0.160261391,0
111,2,Reactome Pathways,,Interleukin-1 signaling,0.0397,SKP1|TP53,35655,35756|35771,0.0021,,HSA-9020702,0.160010915,0
20,2,Monarch Phenotype,,Hodgkin lymphoma,0.0414,TP53|PRKCD,35655,35771|35744,7.80E-05,,HP:0012189,0.157931445,0
66,2,GO Biological Process,,Positive regulation of gliogenesis,0.0417,E2F1|TP73,35655,35768|35774,7.60E-04,,GO:0014015,0.157573363,0
66,2,GO Biological Process,,Cellular response to hydrogen peroxide,0.0417,PRKCD|CDK1,35655,35744|35765,7.60E-04,,GO:0070301,0.157573363,0
739,4,GO Biological Process,,Regulation of proteolysis,0.0425,CASP6|CDK2|TP53|HIPK2,35655,35762|35750|35771|35747,7.80E-04,,GO:0030162,0.156630927,0
434,4,GO Molecular Function,,Protein serine/threonine kinase activity,0.0425,CDK2|PRKCD|CDK1|HIPK2,35655,35750|35744|35765|35747,1.00E-04,,GO:0004674,0.156630927,0
21,2,Monarch Phenotype,,Micronodular cirrhosis,0.0433,TP53|CTNNB1,35655,35771|35753,8.54E-05,,HP:0001413,0.155706067,0
145,3,Monarch Phenotype,,Abnormal venous morphology,0.0433,TP53|PRKCD|CTNNB1,35655,35771|35744|35753,8.68E-05,,HP:0002624,0.155706067,0
314,3,GO Biological Process,,Regulation of cellular response to growth factor stimulus,0.0443,TP53|HIPK2|CTNNB1,35655,35771|35747|35753,8.10E-04,,GO:0090287,0.15457373,0
69,2,GO Biological Process,,Positive regulation of reactive oxygen species metabolic process,0.0446,TP53|PRKCD,35655,35771|35744,8.20E-04,,GO:2000379,0.15423901,0
2131,6,GO Biological Process,,Positive regulation of response to stimulus,0.045,CASP6|TP53|PRKCD|TP73|HIPK2|CTNNB1,35655,35762|35771|35744|35774|35747|35753,8.30E-04,,GO:0048584,0.153796202,0
824,4,TISSUES,,Embryo,0.045,TP53|CASP3|CREB1|CTNNB1,35655,35771|35777|35759|35753,0.0012,,BTO:0000379,0.153796202,0
119,2,Reactome Pathways,,Transcriptional regulation by RUNX2,0.0451,SKP1|CDK1,35655,35756|35765,0.0024,,HSA-8878166,0.153686115,0
70,2,GO Biological Process,,Regulation of osteoclast differentiation,0.0454,CREB1|CTNNB1,35655,35759|35753,8.50E-04,,GO:0045670,0.153357312,0
321,3,GO Biological Process,,Regulation of developmental growth,0.0462,TP73|CDK1|CREB1,35655,35774|35765|35759,8.70E-04,,GO:0048638,0.152491016,0
1373,5,GO Biological Process,,Regulation of response to stress,0.0462,CASP6|TP53|PRKCD|HIPK2|CTNNB1,35655,35762|35771|35744|35747|35753,8.70E-04,,GO:0080134,0.152491016,0
325,3,GO Biological Process,,Cellular response to abiotic stimulus,0.0476,TP53|CASP3|PRKCD,35655,35771|35777|35744,9.00E-04,,GO:0071214,0.151010482,0
462,4,GO Molecular Function,,DNA-binding transcription activator activity,0.0498,TP53|E2F1|TP73|CREB1,35655,35771|35768|35774|35759,1.30E-04,,GO:0001216,0.148769706,0
2188,6,GO Biological Process,,Nervous system development,0.0499,TP53|CASP3|E2F1|HIPK2|CREB1|CTNNB1,35655,35771|35777|35768|35747|35759|35753,9.60E-04,,GO:0007399,0.148670219,0
